BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998;115:182-205. [DOI: 10.1016/s0016-5085(98)70381-6] [Cited by in Crossref: 1456] [Cited by in F6Publishing: 536] [Article Influence: 60.7] [Reference Citation Analysis]
Number Citing Articles
1 Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804-811. [PMID: 11076879 DOI: 10.1136/gut.47.6.804] [Cited by in Crossref: 764] [Cited by in F6Publishing: 733] [Article Influence: 34.7] [Reference Citation Analysis]
2 Machida H, Tsukamoto K, Wen CY, Narumi Y, Shikuwa S, Isomoto H, Takeshima F, Mizuta Y, Niikawa N, Murata I, Kohno S. Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese. World J Gastroenterol 2005; 11(27): 4188-4193 [PMID: 16015687 DOI: 10.3748/wjg.v11.i27.4188] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
3 Burge K, Gunasekaran A, Eckert J, Chaaban H. Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection. Int J Mol Sci 2019;20:E1912. [PMID: 31003422 DOI: 10.3390/ijms20081912] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 12.3] [Reference Citation Analysis]
4 Andoh A, Fujiyama Y. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease. World J Gastroenterol 2006; 12(28): 4452-4460 [PMID: 16874854 DOI: 10.3748/wjg.v12.i28.4452] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
5 Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology. 2002;122:1592-1608. [PMID: 12016425 DOI: 10.1053/gast.2002.33426] [Cited by in Crossref: 226] [Cited by in F6Publishing: 198] [Article Influence: 11.3] [Reference Citation Analysis]
6 Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study. World J Gastroenterol 2003; 9(10): 2300-2307 [PMID: 14562397 DOI: 10.3748/wjg.v9.i10.2300] [Cited by in CrossRef: 173] [Cited by in F6Publishing: 160] [Article Influence: 9.1] [Reference Citation Analysis]
7 Prakash S, Urbanska AM. Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells. Biologics 2008;2:355-78. [PMID: 19707368 DOI: 10.2147/btt.s2372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Ge X, Chen Z, Xu Z, Lv F, Zhang K, Yang Y. The effects of dihydroartemisinin on inflammatory bowel disease-related bone loss in a rat model. Exp Biol Med (Maywood) 2018;243:715-24. [PMID: 29763384 DOI: 10.1177/1535370218769420] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 Diezmos EF, Markus I, Perera DS, Gan S, Zhang L, Sandow SL, Bertrand PP, Liu L. Blockade of Pannexin-1 Channels and Purinergic P2X7 Receptors Shows Protective Effects Against Cytokines-Induced Colitis of Human Colonic Mucosa. Front Pharmacol 2018;9:865. [PMID: 30127744 DOI: 10.3389/fphar.2018.00865] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Deban L, Correale C, Vetrano S, Malesci A, Danese S. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol. 2008;172:1457-1466. [PMID: 18458096 DOI: 10.2353/ajpath.2008.070593] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 6.1] [Reference Citation Analysis]
11 Komine-Aizawa S, Masuda H, Mazaki T, Shiono M, Hayakawa S, Takayama T. Plasma osteopontin predicts inflammatory bowel disease activities. Int Surg 2015;100:38-43. [PMID: 25594638 DOI: 10.9738/INTSURG-D-13-00160.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
12 Shi Y, Li T, Zhou J, Li Y, Chen L, Shang H, Guo Y, Sun Y, Zhao J, Bao C, Wu H. Herbs-Partitioned Moxibustion Combined with Acupuncture Inhibits TGF-β1-Smad-Snail-Induced Intestinal Epithelial Mesenchymal Transition in Crohn's Disease Model Rats. Evid Based Complement Alternat Med 2019;2019:8320250. [PMID: 31275422 DOI: 10.1155/2019/8320250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Ryan P, Bennett MW, Aarons S, Lee G, Collins JK, O’Sullivan GC, O’Connell J, Shanahan F. PCR detection of Mycobacterium paratuberculosis in Crohn’s disease granulomas isolated by laser capture microdissection. Gut. 2002;51:665-670. [PMID: 12377804 DOI: 10.1136/gut.51.5.665] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 4.3] [Reference Citation Analysis]
14 Rigby RJ, Knight SC, Kamm MA, Stagg AJ. Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin Exp Immunol. 2005;139:245-256. [PMID: 15654823 DOI: 10.1111/j.1365-2249.2004.02674.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
15 Mallolas J, Esteve M, Rius E, Cabré E, Gassull MA. Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis. Gut. 2000;47:74-78. [PMID: 10861267 DOI: 10.1136/gut.47.1.74] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
16 Zhao Y, Sun Y, Ding Y, Wang X, Zhou Y, Li W, Huang S, Li Z, Kong L, Guo Q, Lu N. GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK/FOXO3a pathway. Oncotarget. 2015;6:26291-26307. [PMID: 26327408 DOI: 10.18632/oncotarget.4657] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
17 Gao Y, Huang Y, Zhao Y, Hu Y, Li Z, Guo Q, Zhao K, Lu N. LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling. Oncotarget 2016;7:63981-94. [PMID: 27590510 DOI: 10.18632/oncotarget.11742] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
18 Lomax AE, O'Reilly M, Neshat S, Vanner SJ. Sympathetic vasoconstrictor regulation of mouse colonic submucosal arterioles is altered in experimental colitis. J Physiol 2007;583:719-30. [PMID: 17615098 DOI: 10.1113/jphysiol.2007.136838] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
19 Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005;28:187-196. [PMID: 16129903 DOI: 10.1385/criai:28:3:187] [Cited by in Crossref: 176] [Cited by in F6Publishing: 87] [Article Influence: 10.4] [Reference Citation Analysis]
20 Oz HS, Ebersole JL. Green tea polyphenols mediated apoptosis in intestinal epithelial cells by a FADD-dependent pathway. J Cancer Ther. 2010;1:105-113. [PMID: 21687829 DOI: 10.4236/jct.2010.13018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
21 Siegmund B, Zeitz M. Standards of medical treatment and nutrition in Crohn's disease. Langenbecks Arch Surg 2005;390:503-9. [PMID: 15449064 DOI: 10.1007/s00423-004-0498-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Dosh RH, Jordan-Mahy N, Sammon C, Le Maitre C. Interleukin 1 is a key driver of inflammatory bowel disease-demonstration in a murine IL-1Ra knockout model. Oncotarget 2019;10:3559-75. [PMID: 31191826 DOI: 10.18632/oncotarget.26894] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
23 Bruscoli S, Sorcini D, Flamini S, Gagliardi A, Adamo F, Ronchetti S, Migliorati G, Bereshchenko O, Riccardi C. Glucocorticoid-Induced Leucine Zipper Inhibits Interferon-Gamma Production in B Cells and Suppresses Colitis in Mice. Front Immunol 2018;9:1720. [PMID: 30083167 DOI: 10.3389/fimmu.2018.01720] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
24 Krieglstein CF, Cerwinka WH, Sprague AG, Laroux FS, Grisham MB, Koteliansky VE, Senninger N, Granger DN, de Fougerolles AR. Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis. J Clin Invest. 2002;110:1773-1782. [PMID: 12488427 DOI: 10.1172/jci200215256] [Cited by in Crossref: 110] [Cited by in F6Publishing: 1] [Article Influence: 5.8] [Reference Citation Analysis]
25 Sturm A, Rilling K, Baumgart DC, Gargas K, Abou-Ghazalé T, Raupach B, Eckert J, Schumann RR, Enders C, Sonnenborn U. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Infect Immun. 2005;73:1452-1465. [PMID: 15731043 DOI: 10.1128/IAI.73.3.1452-1465] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Boismenu R, Chen Y, Chou K, El-Sheikh A, Buelow R. Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis. Ann Rheum Dis 2002;61 Suppl 2:ii19-24. [PMID: 12379615 DOI: 10.1136/ard.61.suppl_2.ii19] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
27 Narumi Y, Isomoto H, Shiota M, Sato K, Kondo S, Machida H, Yanagihara K, Mizuta Y, Kohno S, Tsukamoto K. Polymorphisms of PTPN11 coding SHP-2 as biomarkers for ulcerative colitis susceptibility in the Japanese population. J Clin Immunol. 2009;29:303-310. [PMID: 19160029 DOI: 10.1007/s10875-008-9272-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
28 Kankuri E, Vaali K, Korpela R, Paakkari I, Vapaatalo H, Moilanen E. Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. Inflammation. 2001;25:301-310. [PMID: 11820457 DOI: 10.1023/a:1012860509440] [Cited by in Crossref: 38] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
29 Eloy P, Leruth E, Goffart Y, Nollevaux MC, Fridman V, Dartevelle M, Melange M, Daele J, Bertrand B. Sinonasal involvement as a rare extraintestinal manifestation of Crohn's disease. Eur Arch Otorhinolaryngol 2007;264:103-8. [PMID: 17021783 DOI: 10.1007/s00405-006-0146-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
30 Franchimont N, Reenaers C, Lambert C, Belaiche J, Bours V, Malaise M, Delvenne P, Louis E. Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin Exp Immunol 2004;138:491-8. [PMID: 15544627 DOI: 10.1111/j.1365-2249.2004.02643.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
31 Park JS, Joe I, Rhee PD, Jeong CS, Jeong G. A lactic acid bacterium isolated from kimchi ameliorates intestinal inflammation in DSS-induced colitis. J Microbiol. 2017;55:304-310. [PMID: 28124779 DOI: 10.1007/s12275-017-6447-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
32 Sheil B, MacSharry J, O'Callaghan L, O'Riordan A, Waters A, Morgan J, Collins JK, O'Mahony L, Shanahan F. Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice. Clin Exp Immunol 2006;144:273-80. [PMID: 16634801 DOI: 10.1111/j.1365-2249.2006.03051.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
33 Liptay S, Bachem M, Häcker G, Adler G, Debatin KM, Schmid RM. Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine. Br J Pharmacol. 1999;128:1361-1369. [PMID: 10602313 DOI: 10.1038/sj.bjp.0702937] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 2.7] [Reference Citation Analysis]
34 Dieleman LA, Goerres MS, Arends A, Sprengers D, Torrice C, Hoentjen F, Grenther WB, Sartor RB. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut. 2003;52:370-376. [PMID: 12584218 DOI: 10.1136/gut.52.3.370] [Cited by in Crossref: 155] [Cited by in F6Publishing: 142] [Article Influence: 8.2] [Reference Citation Analysis]
35 Müller M, Fink K, Geisel J, Kahl F, Jilge B, Reimann J, Mach N, Autenrieth IB, Frick JS. Intestinal colonization of IL-2 deficient mice with non-colitogenic B. vulgatus prevents DC maturation and T-cell polarization. PLoS One. 2008;3:e2376. [PMID: 18545662 DOI: 10.1371/journal.pone.0002376] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
36 Magyari L, Faragó B, Bene J, Horvatovich K, Lakner L, Varga M, Figler M, Gasztonyi B, Mózsik G, Melegh B. No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn’s disease and ulcerative colitis in Hungarian population samples. World J Gastroenterol 2007; 13(15): 2205-2208 [PMID: 17465502 DOI: 10.3748/wjg.v13.i15.2205] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
37 Li L, Xu P, Zhang Z, Zhou X, Chen C, Lu C. Platelets can reflect the severity of Crohn's disease without the effect of anemia. Clinics (Sao Paulo) 2020;75:e1596. [PMID: 32667493 DOI: 10.6061/clinics/2020/e1596] [Reference Citation Analysis]
38 Ludwig K, Fassan M, Mescoli C, Pizzi M, Balistreri M, Albertoni L, Pucciarelli S, Scarpa M, Sturniolo GC, Angriman I. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. Virchows Arch. 2013;462:57-63. [PMID: 23224068 DOI: 10.1007/s00428-012-1345-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
39 Kim SJ, Kim MC, Um JY, Hong SH. The beneficial effect of vanillic acid on ulcerative colitis. Molecules 2010;15:7208-17. [PMID: 20959795 DOI: 10.3390/molecules15107208] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 7.2] [Reference Citation Analysis]
40 Day AS, Gearry RB. Rifaximin and Crohn's disease: a new solution to an old problem? Dig Dis Sci 2010;55:877-9. [PMID: 20155320 DOI: 10.1007/s10620-010-1140-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
41 Shimamoto M, Ueno Y, Tanaka S, Onitake T, Hanaoka R, Yoshioka K, Hatakeyama T, Chayama K. Selective decrease in colonic CD56+ T and CD161+ T cells in the inflamed mucosa of patients with ulcerative colitis. World J Gastroenterol 2007; 13(45): 5995-6002 [DOI: 10.3748/wjg.v13.i45.5995] [Reference Citation Analysis]
42 Powell JJ, Van de Water J, Gershwin ME. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect 1999;107 Suppl 5:667-72. [PMID: 10970167 DOI: 10.1289/ehp.99107s5667] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
43 Jing B, Wang ZA, Zhang C, Deng Q, Wei J, Luo Y, Zhang X, Li J, Du Y. Establishment and Application of Peristaltic Human Gut-Vessel Microsystem for Studying Host-Microbial Interaction. Front Bioeng Biotechnol 2020;8:272. [PMID: 32296697 DOI: 10.3389/fbioe.2020.00272] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
44 Heuschen G, Leowardi C, Hinz U, Autschbach F, Stallmach A, Herfarth C, Heuschen UA. Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients. Int J Colorectal Dis 2007;22:293-301. [PMID: 16770571 DOI: 10.1007/s00384-006-0133-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
45 Li P, Liang ML, Zhu Y, Gong YY, Wang Y, Heng D, Lin L. Resveratrol inhibits collagen I synthesis by suppressing IGF-1R activation in intestinal fibroblasts. World J Gastroenterol 2014; 20(16): 4648-4661 [PMID: 24782617 DOI: 10.3748/wjg.v20.i16.4648] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
46 Samaan MA, Pavlidis P, Papa S, Powell N, Irving PM. Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management. Nat Rev Gastroenterol Hepatol. 2018;15:222-234. [PMID: 29512649 DOI: 10.1038/nrgastro.2018.14] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 10.5] [Reference Citation Analysis]
47 Lindsay JO, Ciesielski CJ, Scheinin T, Brennan FM, Hodgson HJ. Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis. Gut. 2003;52:981-987. [PMID: 12801955 DOI: 10.1136/gut.52.7.981] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
48 Eriksson A, Flach CF, Lindgren A, Kvifors E, Lange S. Five mucosal transcripts of interest in ulcerative colitis identified by quantitative real-time PCR: a prospective study. BMC Gastroenterol 2008;8:34. [PMID: 18700007 DOI: 10.1186/1471-230X-8-34] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
49 Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem. 2010;285:20202-20212. [PMID: 20363741 DOI: 10.1074/jbc.m110.102012] [Cited by in Crossref: 158] [Cited by in F6Publishing: 98] [Article Influence: 13.2] [Reference Citation Analysis]
50 Zhang M, Collins JF, Merlin D. Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases? Nanomedicine (Lond) 2016;11:3035-7. [PMID: 27813445 DOI: 10.2217/nnm-2016-0353] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
51 Gonçalves CC, Hernandes L, Bersani-Amado CA, Franco SL, Silva JF, Natali MR. Use of propolis hydroalcoholic extract to treat colitis experimentally induced in rats by 2,4,6-trinitrobenzenesulfonic Acid. Evid Based Complement Alternat Med 2013;2013:853976. [PMID: 24101941 DOI: 10.1155/2013/853976] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
52 Wang Q, Yang K, Han B, Sheng B, Yin J, Pu A, Li L, Sun L, Yu M, Qiu Y, Xiao W, Yang H. Aryl hydrocarbon receptor inhibits inflammation in DSS‑induced colitis via the MK2/p‑MK2/TTP pathway. Int J Mol Med 2018;41:868-76. [PMID: 29207040 DOI: 10.3892/ijmm.2017.3262] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
53 Kanodia L, Borgohain M, Das S. Effect of fruit extract of Fragaria vesca L. on experimentally induced inflammatory bowel disease in albino rats. Indian J Pharmacol 2011;43:18-21. [PMID: 21455415 DOI: 10.4103/0253-7613.75660] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
54 Jones NP, Siegle GJ, Proud L, Silk JS, Hardy D, Keljo DJ, Dahl RE, Szigethy E. Impact of inflammatory bowel disease and high-dose steroid exposure on pupillary responses to negative information in pediatric depression. Psychosom Med. 2011;73:151-157. [PMID: 21217099 DOI: 10.1097/PSY.0b013e318207ffea] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
55 Mo JS, Na KS, Yu JI, Chae SC. Identification of the polymorphisms in IFITM1 gene and their association in a Korean population with ulcerative colitis. Immunol Lett 2013;156:118-22. [PMID: 24120510 DOI: 10.1016/j.imlet.2013.09.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
56 Lamichhane S, Mo JS, Sharma G, Choi TY, Chae SC. MicroRNA 452 regulates IL20RA-mediated JAK1/STAT3 pathway in inflammatory colitis and colorectal cancer. Inflamm Res 2021;70:903-14. [PMID: 34283251 DOI: 10.1007/s00011-021-01486-7] [Reference Citation Analysis]
57 Lindsay JO, Ciesielski CJ, Scheinin T, Brennan FM, Hodgson HJ. Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis. Gut. 2003;52:363-369. [PMID: 12584217 DOI: 10.1136/gut.52.3.363] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
58 Celiberto LS, Bedani R, Dejani NN, Ivo de Medeiros A, Sampaio Zuanon JA, Spolidorio LC, Tallarico Adorno MA, Amâncio Varesche MB, Carrilho Galvão F, Valentini SR, Font de Valdez G, Rossi EA, Cavallini DCU. Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis. PLoS One 2017;12:e0175935. [PMID: 28437455 DOI: 10.1371/journal.pone.0175935] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
59 Bisping G, Lugering N, Lutke-Brintrup S, Pauels HG, Schurmann G, Domschke W, Kucharzik T. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells. Clin Exp Immunol. 2001;123:15-22. [PMID: 11167992 DOI: 10.1046/j.1365-2249.2001.01443.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 2.1] [Reference Citation Analysis]
60 Johansson ME, Gustafsson JK, Holmén-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sjövall H. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2014;63:281-291. [PMID: 23426893 DOI: 10.1136/gutjnl-2012-303207] [Cited by in Crossref: 433] [Cited by in F6Publishing: 434] [Article Influence: 48.1] [Reference Citation Analysis]
61 Damin DC, Santos FS, Heck R, Rosito MA, Meurer L, Kliemann LM, Roesler R, Schwartsmann G. Effects of the gastrin-releasing peptide antagonist RC-3095 in a rat model of ulcerative colitis. Dig Dis Sci 2010;55:2203-10. [PMID: 19894117 DOI: 10.1007/s10620-009-1032-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
62 Card T, Logan RF, Rodrigues LC, Wheeler JG. Antibiotic use and the development of Crohn's disease. Gut 2004;53:246-50. [PMID: 14724158 DOI: 10.1136/gut.2003.025239] [Cited by in Crossref: 96] [Cited by in F6Publishing: 88] [Article Influence: 5.3] [Reference Citation Analysis]
63 Ogura Y, Lala S, Xin W, Smith E, Dowds TA, Chen FF, Zimmermann E, Tretiakova M, Cho JH, Hart J. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut. 2003;52:1591-1597. [PMID: 14570728 DOI: 10.1136/gut.52.11.1591] [Cited by in Crossref: 296] [Cited by in F6Publishing: 287] [Article Influence: 16.4] [Reference Citation Analysis]
64 Guo H, Xu Y, Huang W, Zhou H, Zheng Z, Zhao Y, He B, Zhu T, Tang S, Zhu Q. Kuwanon G Preserves LPS-Induced Disruption of Gut Epithelial Barrier In Vitro. Molecules 2016;21:E1597. [PMID: 27879681 DOI: 10.3390/molecules21111597] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
65 Chen J, Gao ML, Bai XR, Cui H, Wang MZ. Expression of NF-κB and cytokines in human ulcerative colitis and its significance. Shijie Huaren Xiaohua Zazhi 2009; 17(2): 209-212 [DOI: 10.11569/wcjd.v17.i2.209] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Barton SG, Rampton DS, Winrow VR, Domizio P, Feakins RM. Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones 2003;8:329-34. [PMID: 15115285 DOI: 10.1379/1466-1268(2003)008<0329:eohsph>2.0.co;2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
67 Kwon HS, Oh SM, Kim JK. Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis. Clin Exp Immunol. 2008;151:165-173. [PMID: 18005263 DOI: 10.1111/j.1365-2249.2007.03539.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 4.5] [Reference Citation Analysis]
68 Matsushita M, Takakuwa H, Matsubayashi Y, Nishio A, Ikehara S, Okazaki K. Appendix is a priming site in the development of ulcerative colitis. World J Gastroenterol 2005; 11(31): 4869-4874 [PMID: 16097061 DOI: 10.3748/wjg.v11.i31.4869] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
69 Danese S, Fiorino G, Angelucci E, Vetrano S, Pagano N, Rando G, Spinelli A, Malesci A, Repici A. Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: A pilot study. World J Gastroenterol 2010; 16(19): 2396-2400 [PMID: 20480525 DOI: 10.3748/wjg.v16.i19.2396] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
70 Smith JP, Bingaman SI, Ruggiero F, Mauger DT, Mukherjee A, McGovern CO, Zagon IS. Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn’s disease: a randomized placebo-controlled trial. Dig Dis Sci. 2011;56:2088-2097. [PMID: 21380937 DOI: 10.1007/s10620-011-1653-7] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 6.0] [Reference Citation Analysis]
71 Riboulet-Bisson E, Sturme MH, Jeffery IB, O'Donnell MM, Neville BA, Forde BM, Claesson MJ, Harris H, Gardiner GE, Casey PG, Lawlor PG, O'Toole PW, Ross RP. Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota. PLoS One 2012;7:e31113. [PMID: 22363561 DOI: 10.1371/journal.pone.0031113] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 9.2] [Reference Citation Analysis]
72 Meiners J, Palmieri V, Klopfleisch R, Ebel JF, Japtok L, Schumacher F, Yusuf AM, Becker KA, Zöller J, Hose M, Kleuser B, Hermann DM, Kolesnick RN, Buer J, Hansen W, Westendorf AM. Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis. Front Immunol 2019;10:1386. [PMID: 31275322 DOI: 10.3389/fimmu.2019.01386] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
73 Zingarelli B, Hake PW, Burroughs TJ, Piraino G, O’connor M, Denenberg A. Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis. Immunology. 2004;113:509-517. [PMID: 15554929 DOI: 10.1111/j.1365-2567.2004.01991.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
74 Wagner J, Sim WH, Ellis JA, Ong EK, Catto-Smith AG, Cameron DJ, Bishop RF, Kirkwood CD. Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort. PLoS One 2010;5:e15376. [PMID: 21079743 DOI: 10.1371/journal.pone.0015376] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
75 Lee LH, Iacucci M, Fort Gasia M, Ghosh S, Panaccione R, Urbanski S. Prevalence and Anatomic Distribution of Serrated and Adenomatous Lesions in Patients with Inflammatory Bowel Disease. Can J Gastroenterol Hepatol 2017;2017:5490803. [PMID: 28182112 DOI: 10.1155/2017/5490803] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
76 Wang K, Yuan CP, Wang W, Yang ZQ, Cui W, Mu LZ, Yue ZP, Yin XL, Hu ZM, Liu JX. Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis. World J Gastroenterol 2010; 16(18): 2252-2259 [PMID: 20458762 DOI: 10.3748/wjg.v16.i18.2252] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
77 Chen J, Yang S, Hu S, Choudhry MA, Bland KI, Chaudry IH. Estrogen prevents intestinal inflammation after trauma-hemorrhage via downregulation of angiotensin II and angiotensin II subtype I receptor. Am J Physiol Gastrointest Liver Physiol 2008;295:G1131-7. [PMID: 18832446 DOI: 10.1152/ajpgi.90443.2008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
78 Prantera C. Probiotics for Crohn's disease: what have we learned? Gut 2006;55:757-9. [PMID: 16698749 DOI: 10.1136/gut.2005.085381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
79 Vaji S, Salehi Z, Aminian K. Association of p53 codon 72 genetic polymorphism with the risk of ulcerative colitis in northern Iran. Int J Colorectal Dis 2011;26:235-8. [PMID: 20669023 DOI: 10.1007/s00384-010-1021-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
80 Banerjee R, Balaji M, Sasikala M, Anuradha S, Rao GV, Nageshwar Reddy D. Granulomas of intestinal tuberculosis and Crohn's disease can be differentiated by CD73 cell surface marker expression: a pilot study. Dig Dis Sci. 2013;58:2301-2307. [PMID: 23625284 DOI: 10.1007/s10620-013-2667-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
81 Kriegel C, Amiji MM. Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease. Clin Transl Gastroenterol. 2011;2:e2. [PMID: 23237848 DOI: 10.1038/ctg.2011.1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
82 Morohoshi Y, Matsuoka K, Chinen H, Kamada N, Sato T, Hisamatsu T, Okamoto S, Inoue N, Takaishi H, Ogata H. Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis. J Gastroenterol. 2006;41:318-324. [PMID: 16741610 DOI: 10.1007/s00535-005-1768-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
83 Machida H, Tsukamoto K, Wen CY, Shikuwa S, Isomoto H, Mizuta Y, Takeshima F, Murase K, Matsumoto N, Murata I, Kohno S, Wen CY. Crohn’s disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene. World J Gastroenterol 2005; 11(31): 4833-4837 [PMID: 16097053 DOI: 10.3748/wjg.v11.i31.4833] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
84 Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, Fiocchi C. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003;52:1435-41. [PMID: 12970136 DOI: 10.1136/gut.52.10.1435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
85 Oh WS, Jung JC, Choi YM, Mun JY, Ku SK, Song CH. Protective effects of fermented rice extract on ulcerative colitis induced by dextran sodium sulfate in mice. Food Sci Nutr 2020;8:1718-28. [PMID: 32180979 DOI: 10.1002/fsn3.1460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M, Baggiolini M. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol. 1999;155:331-336. [PMID: 10433925 DOI: 10.1016/s0002-9440(10)65128-0] [Cited by in Crossref: 194] [Cited by in F6Publishing: 69] [Article Influence: 8.4] [Reference Citation Analysis]
87 Millán Scheiding M, Rodriguez Moranta F, Kreisler Moreno E, Golda T, Fraccalvieri D, Biondo S. [Current status of elective surgical treatment of ulcerative colitis. A systematic review]. Cir Esp 2012;90:548-57. [PMID: 23063060 DOI: 10.1016/j.ciresp.2012.07.019] [Reference Citation Analysis]
88 Smalley-Freed WG, Efimov A, Burnett PE, Short SP, Davis MA, Gumucio DL, Washington MK, Coffey RJ, Reynolds AB. p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice. J Clin Invest 2010;120:1824-35. [PMID: 20484816 DOI: 10.1172/JCI41414] [Cited by in Crossref: 93] [Cited by in F6Publishing: 74] [Article Influence: 7.8] [Reference Citation Analysis]
89 Bouatrouss Y, Herring-Gillam FE, Gosselin J, Poisson J, Beaulieu JF. Altered expression of laminins in Crohn's disease small intestinal mucosa. Am J Pathol 2000;156:45-50. [PMID: 10623652 DOI: 10.1016/S0002-9440(10)64704-9] [Cited by in Crossref: 46] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
90 McLaughlin SD, Clark SK, Tekkis PP, Nicholls RJ, Ciclitira PJ. The bacterial pathogenesis and treatment of pouchitis. Therap Adv Gastroenterol. 2010;3:335-348. [PMID: 21180613 DOI: 10.1177/1756283x10370611] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
91 Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y, Ishimaru N. Role of regulatory T cell in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2016; 22(7): 2195-2205 [PMID: 26900284 DOI: 10.3748/wjg.v22.i7.2195] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 78] [Article Influence: 14.0] [Reference Citation Analysis]
92 Ricci S, Macchia G, Ruggiero P, Maggi T, Bossù P, Xu L, Medaglini D, Tagliabue A, Hammarström L, Pozzi G, Boraschi D. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii. BMC Biotechnol 2003;3:15. [PMID: 13129437 DOI: 10.1186/1472-6750-3-15] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
93 Kountouras J, Zavos C, Chatzopoulos D. Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease. J Cell Mol Med 2004;8:317-28. [PMID: 15491507 DOI: 10.1111/j.1582-4934.2004.tb00321.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
94 Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, Wolf AM, Tilg H. The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut. 2005;54:479-487. [PMID: 15753532 DOI: 10.1136/gut.2004.044370] [Cited by in Crossref: 156] [Cited by in F6Publishing: 132] [Article Influence: 9.2] [Reference Citation Analysis]
95 Toiyama Y, Mizoguchi A, Kimura K, Araki T, Yoshiyama S, Sakaguchi K, Miki C, Kusunoki M. Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma. World J Gastroenterol 2005; 11(33): 5151-5155 [PMID: 16127744 DOI: 10.3748/wjg.v11.i33.5151] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
96 Cestari SH, Bastos JK, Di Stasi LC. Intestinal Anti-Inflammatory Activity of Baccharis dracunculifolia in the Trinitrobenzenesulphonic Acid Model of Rat Colitis. Evid Based Complement Alternat Med 2011;2011:524349. [PMID: 19592480 DOI: 10.1093/ecam/nep081] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
97 Schultz M, Munro K, Tannock GW, Melchner I, Göttl C, Schwietz H, Schölmerich J, Rath HC. Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats. Clin Diagn Lab Immunol 2004;11:581-7. [PMID: 15138186 DOI: 10.1128/CDLI.11.3.581-587.2004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
98 Collins CB, Ho J, Wilson TE, Wermers JD, Tlaxca JL, Lawrence MB, Solga M, Lannigan J, Rivera-Nieves J. CD44 deficiency attenuates chronic murine ileitis. Gastroenterology 2008;135:1993-2002. [PMID: 18854186 DOI: 10.1053/j.gastro.2008.08.053] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
99 Hochepied T, Wullaert A, Berger FG, Baumann H, Brouckaert P, Steidler L, Libert C. Overexpression of alpha(1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis. Gut 2002;51:398-404. [PMID: 12171963 DOI: 10.1136/gut.51.3.398] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
100 Mendlovic F, Cruz-Rivera M, Diaz-Gandarilla JA, Flores-Torres MA, Avila G, Perfiliev M, Salazar AM, Arriaga-Pizano L, Ostrosky-Wegman P, Flisser A. Orally administered Taenia solium Calreticulin prevents experimental intestinal inflammation and is associated with a type 2 immune response. PLoS One 2017;12:e0186510. [PMID: 29036211 DOI: 10.1371/journal.pone.0186510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
101 Sun L, Dong H, Zhang Z, Liu J, Hu Y, Ni Y, Grossmann R, Zhao R. Activation of epithelial proliferation induced by Eimeria acervulina infection in the duodenum may be associated with cholesterol metabolism. Oncotarget 2016;7:27627-40. [PMID: 27050279 DOI: 10.18632/oncotarget.8490] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
102 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(11): 1782-1786 [DOI: 10.11569/wcjd.v11.i11.1782] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
103 Sang LX, Chang B, Zhu JF, Yang FL, Li Y, Jiang XF, Wang DN, Lu CL, Sun X. Sodium selenite ameliorates dextran sulfate sodium-induced chronic colitis in mice by decreasing Th1, Th17, and γδT and increasing CD4(+)CD25(+) regulatory T-cell responses. World J Gastroenterol 2017; 23(21): 3850-3863 [PMID: 28638225 DOI: 10.3748/wjg.v23.i21.3850] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
104 Chivese T, Esterhuizen TM, Basson AR, Watermeyer G. The Influence of Second-Hand Cigarette Smoke Exposure during Childhood and Active Cigarette Smoking on Crohn's Disease Phenotype Defined by the Montreal Classification Scheme in a Western Cape Population, South Africa. PLoS One 2015;10:e0139597. [PMID: 26422615 DOI: 10.1371/journal.pone.0139597] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
105 Zanin V, Segat L, Bianco AM, Padovan L, Tavares Nde A, Crovella S. DEFB1 gene 5' untranslated region (UTR) polymorphisms in inflammatory bowel diseases. Clinics (Sao Paulo) 2012;67:395-8. [PMID: 22522766 DOI: 10.6061/clinics/2012(04)14] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
106 Lai CY, Yeh KY, Liu BF, Chang TM, Chang CH, Liao YF, Liu YW, Her GM. MicroRNA-21 Plays Multiple Oncometabolic Roles in Colitis-Associated Carcinoma and Colorectal Cancer via the PI3K/AKT, STAT3, and PDCD4/TNF-α Signaling Pathways in Zebrafish. Cancers (Basel) 2021;13:5565. [PMID: 34771727 DOI: 10.3390/cancers13215565] [Reference Citation Analysis]
107 Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 2009;296:G135-46. [PMID: 19033538 DOI: 10.1152/ajpgi.90462.2008] [Cited by in Crossref: 259] [Cited by in F6Publishing: 261] [Article Influence: 18.5] [Reference Citation Analysis]
108 Jung Y, Rothenberg ME. Roles and regulation of gastrointestinal eosinophils in immunity and disease. J Immunol. 2014;193:999-1005. [PMID: 25049430 DOI: 10.4049/jimmunol.1400413] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 9.1] [Reference Citation Analysis]
109 Li K, Wang B, Sui H, Liu S, Yao S, Guo L, Mao D. Polymorphisms of the macrophage inflammatory protein 1 alpha and ApoE genes are associated with ulcerative colitis. Int J Colorectal Dis. 2009;24:13-17. [PMID: 18762952 DOI: 10.1007/s00384-008-0575-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
110 Hanai H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol 2006; 12(47): 7568-7577 [PMID: 17171783 DOI: 10.3748/wjg.v12.i47.7568] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
111 Polese L, De Franchis G, Scarpa M, Sturniolo GC, Ruffolo C, Norberto L, Frego M, D'Amico DF, Angriman I. B1a lymphocytes in ulcerative colitis. Int J Colorectal Dis. 2007;22:1005-1011. [PMID: 17372743 DOI: 10.1007/s00384-007-0298-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
112 Kitani A, Fuss IJ, Nakamura K, Schwartz OM, Usui T, Strober W. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J Exp Med. 2000;192:41-52. [PMID: 10880525 DOI: 10.1084/jem.192.1.41] [Cited by in Crossref: 131] [Cited by in F6Publishing: 128] [Article Influence: 6.0] [Reference Citation Analysis]
113 Liu Q, Zuo R, Wang K, Nong FF, Fu YJ, Huang SW, Pan ZF, Zhang Y, Luo X, Deng XL, Zhang XX, Zhou L, Chen Y. Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway. Acta Pharmacol Sin 2020;41:771-81. [PMID: 31937929 DOI: 10.1038/s41401-019-0335-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
114 Dong F, Perdew GH. The aryl hydrocarbon receptor as a mediator of host-microbiota interplay. Gut Microbes 2020;12:1859812. [PMID: 33382356 DOI: 10.1080/19490976.2020.1859812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
115 Spencer AU, Yang H, Haxhija EQ, Wildhaber BE, Greenson JK, Teitelbaum DH. Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition. Dig Dis Sci 2007;52:1060-70. [PMID: 17342403 DOI: 10.1007/s10620-006-9124-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
116 Wight TN, Potter-Perigo S. The extracellular matrix: an active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol 2011;301:G950-5. [PMID: 21512158 DOI: 10.1152/ajpgi.00132.2011] [Cited by in Crossref: 126] [Cited by in F6Publishing: 125] [Article Influence: 11.5] [Reference Citation Analysis]
117 Fagundes RR, Bourgonje AR, Saeed A, Vich Vila A, Plomp N, Blokzijl T, Sadaghian Sadabad M, von Martels JZH, van Leeuwen SS, Weersma RK, Dijkstra G, Harmsen HJM, Faber KN. Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium. Gut Microbes 2021;13:1993582. [PMID: 34793284 DOI: 10.1080/19490976.2021.1993582] [Reference Citation Analysis]
118 Hultkrantz S, Ostman S, Telemo E. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration. Immunology. 2005;116:362-372. [PMID: 16236126 DOI: 10.1111/j.1365-2567.2005.02236.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
119 Morys JM, Kaczówka A, Jeżewska M. Assessment of selected psychological factors in patients with inflammatory bowel disease. Prz Gastroenterol 2016;11:47-53. [PMID: 27110311 DOI: 10.5114/pg.2015.52560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
120 Berrebi D, Maudinas R, Hugot JP, Chamaillard M, Chareyre F, De Lagausie P, Yang C, Desreumaux P, Giovannini M, Cezard JP. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut. 2003;52:840-846. [PMID: 12740340 DOI: 10.1136/gut.52.6.840] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 5.3] [Reference Citation Analysis]
121 Cuadrado E, Alonso M, Juan MD, Echaniz P, Arenas JI. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis. World J Gastroenterol 2008; 14(10): 1521-1527 [PMID: 18330941 DOI: 10.3748/wjg.14.1521] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
122 Ruyssers NE, De Winter BY, De Man JG, Ruyssers ND, Van Gils AJ, Loukas A, Pearson MS, Weinstock JV, Pelckmans PA, Moreels TG. Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice. World J Gastroenterol 2010; 16(6): 703-712 [PMID: 20135718 DOI: 10.3748/wjg.v16.i6.703] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
123 Joo YE, Karrasch T, Mühlbauer M, Allard B, Narula A, Herfarth HH, Jobin C. Tomato lycopene extract prevents lipopolysaccharide-induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice. PLoS One 2009;4:e4562. [PMID: 19234608 DOI: 10.1371/journal.pone.0004562] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
124 Lyons DO, Pullen NA. Beyond IgE: Alternative Mast Cell Activation Across Different Disease States. Int J Mol Sci 2020;21:E1498. [PMID: 32098318 DOI: 10.3390/ijms21041498] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
125 Denis MC, Furtos A, Dudonné S, Montoudis A, Garofalo C, Desjardins Y, Delvin E, Levy E. Apple peel polyphenols and their beneficial actions on oxidative stress and inflammation. PLoS One 2013;8:e53725. [PMID: 23372666 DOI: 10.1371/journal.pone.0053725] [Cited by in Crossref: 81] [Cited by in F6Publishing: 71] [Article Influence: 9.0] [Reference Citation Analysis]
126 Krieglstein CF, Cerwinka WH, Sprague AG, Laroux FS, Grisham MB, Koteliansky VE, Senninger N, Granger DN, de Fougerolles AR. Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis. J Clin Invest 2002;110:1773-82. [PMID: 12488427 DOI: 10.1172/JCI15256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 56] [Article Influence: 0.3] [Reference Citation Analysis]
127 Erickson AR, Cantarel BL, Lamendella R, Darzi Y, Mongodin EF, Pan C, Shah M, Halfvarson J, Tysk C, Henrissat B. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn’s disease. PLoS One. 2012;7:e49138. [PMID: 23209564 DOI: 10.1371/journal.pone.0049138] [Cited by in Crossref: 298] [Cited by in F6Publishing: 264] [Article Influence: 29.8] [Reference Citation Analysis]
128 Zurita-Turk M, Del Carmen S, Santos AC, Pereira VB, Cara DC, Leclercq SY, de LeBlanc Ad, Azevedo V, Chatel JM, LeBlanc JG, Miyoshi A. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis. BMC Biotechnol 2014;14:73. [PMID: 25106058 DOI: 10.1186/1472-6750-14-73] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
129 Ismail Y, Mahendran V, Octavia S, Day AS, Riordan SM, Grimm MC, Lan R, Lemberg D, Tran TA, Zhang L. Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease. PLoS One 2012;7:e38217. [PMID: 22666490 DOI: 10.1371/journal.pone.0038217] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.8] [Reference Citation Analysis]
130 Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Emerging evidence on the pathobiology of mucositis. Support Care Cancer 2013;21:3233-41. [PMID: 23842598 DOI: 10.1007/s00520-013-1900-x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 8.6] [Reference Citation Analysis]
131 Seo GS, Lee JK, Yu JI, Yun KJ, Chae SC, Choi SC. Identification of the polymorphisms in IFITM3 gene and their association in a Korean population with ulcerative colitis. Exp Mol Med 2010;42:99-104. [PMID: 19946179 DOI: 10.3858/emm.2010.42.2.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
132 Yu JI, Kang IH, Seo GS, Choi SC, Yun KJ, Chae SC. Promoter polymorphism of the EED gene is associated with the susceptibility to ulcerative colitis. Dig Dis Sci 2012;57:1537-43. [PMID: 22271413 DOI: 10.1007/s10620-012-2045-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
133 Robertson RC, Guihéneuf F, Bahar B, Schmid M, Stengel DB, Fitzgerald GF, Ross RP, Stanton C. The Anti-Inflammatory Effect of Algae-Derived Lipid Extracts on Lipopolysaccharide (LPS)-Stimulated Human THP-1 Macrophages. Mar Drugs 2015;13:5402-24. [PMID: 26308008 DOI: 10.3390/md13085402] [Cited by in Crossref: 73] [Cited by in F6Publishing: 57] [Article Influence: 10.4] [Reference Citation Analysis]
134 Nahidi L, Leach ST, Mitchell HM, Kaakoush NO, Lemberg DA, Munday JS, Huinao K, Day AS. Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed Res Int. 2013;2013:909613. [PMID: 24027765 DOI: 10.1155/2013/909613] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
135 Kankuri E, Vaali K, Korpela R, Paakkari I, Vapaatalo H, Moilanen E. Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. Inflammation. 2001;25:301-310. [PMID: 11820457 DOI: 10.1023/a: 1012860509440] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
136 Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, Tsuboi K, Sugimoto Y, Kobayashi T, Miyachi Y. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest. 2002;109:883-893. [PMID: 11927615 DOI: 10.1172/jci0214459] [Cited by in Crossref: 311] [Cited by in F6Publishing: 1] [Article Influence: 15.6] [Reference Citation Analysis]
137 O'Rourke JL, Grehan M, Lee A. Non-pylori Helicobacter species in humans. Gut 2001;49:601-6. [PMID: 11600455 DOI: 10.1136/gut.49.5.601] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
138 Chakilam S, Gandesiri M, Rau TT, Agaimy A, Vijayalakshmi M, Ivanovska J, Wirtz RM, Schulze-Luehrmann J, Benderska N, Wittkopf N, Chellappan A, Ruemmele P, Vieth M, Rave-Fränk M, Christiansen H, Hartmann A, Neufert C, Atreya R, Becker C, Steinberg P, Schneider-Stock R. Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells. Am J Pathol 2013;182:1005-20. [PMID: 23438478 DOI: 10.1016/j.ajpath.2012.11.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
139 Bondarenko KR, Dobrokhotova YE, Rumyantseva TA, Nasyrova NI. Crohn's disease of the vulva: A tough diagnosis (a case report of a 47 y.o. patient). Clin Case Rep 2020;8:563-7. [PMID: 32185060 DOI: 10.1002/ccr3.2707] [Reference Citation Analysis]
140 Marceau M, Dubuquoy L, Caucheteux-Rousseaux C, Foligne B, Desreumaux P, Simonet M. Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse. Infect Immun. 2004;72:2438-2441. [PMID: 15039377 DOI: 10.1128/iai.72.4.2438-2441.2004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
141 Shen S, Prame Kumar K, Stanley D, Moore RJ, Van TTH, Wen SW, Hickey MJ, Wong CHY. Invariant Natural Killer T Cells Shape the Gut Microbiota and Regulate Neutrophil Recruitment and Function During Intestinal Inflammation. Front Immunol 2018;9:999. [PMID: 29867976 DOI: 10.3389/fimmu.2018.00999] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
142 Zaki MH, Vogel P, Malireddi RK, Body-Malapel M, Anand PK, Bertin J, Green DR, Lamkanfi M, Kanneganti TD. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell. 2011;20:649-660. [PMID: 22094258 DOI: 10.1016/j.ccr.2011.10.022] [Cited by in Crossref: 242] [Cited by in F6Publishing: 244] [Article Influence: 24.2] [Reference Citation Analysis]
143 Tarris G, de Rougemont A, Charkaoui M, Michiels C, Martin L, Belliot G. Enteric Viruses and Inflammatory Bowel Disease. Viruses 2021;13:104. [PMID: 33451106 DOI: 10.3390/v13010104] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Sasaki S, Ishida Y, Nishio N, Ito S, Isobe K. Thymic involution correlates with severe ulcerative colitis induced by oral administration of dextran sulphate sodium in C57BL/6 mice but not in BALB/c mice. Inflammation. 2008;31:319-328. [PMID: 18696222 DOI: 10.1007/s10753-008-9081-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
145 Park JS, Yi TG, Park JM, Han YM, Kim JH, Shin DH, Tak SJ, Lee K, Lee YS, Jeon MS. Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease. J Clin Biochem Nutr. 2015;57:192-203. [PMID: 26566304 DOI: 10.3164/jcbn.15-56] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
146 Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Alterations in the function of circulating mononuclear cells derived from patients with Crohn’s disease treated with mastic. World J Gastroenterol. 2007;13:6031-6036. [PMID: 18023095 DOI: 10.3748/wjg.13.6031] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
147 Chong Y, Han C, Li J, Long X. Mapping global research trends in stem cell therapy for inflammatory bowel disease: a bibliometric analysis from 1991 to 2019. J Int Med Res 2020;48:300060520965824. [PMID: 33115290 DOI: 10.1177/0300060520965824] [Reference Citation Analysis]
148 Kelly D, Conway S. Genomics at work: the global gene response to enteric bacteria. Gut 2001;49:612-3. [PMID: 11600459 DOI: 10.1136/gut.49.5.612] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
149 von Martels JZH, Bourgonje AR, Klaassen MAY, Alkhalifah HAA, Sadaghian Sadabad M, Vich Vila A, Gacesa R, Gabriëls RY, Steinert RE, Jansen BH, Bulthuis MLC, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, de Vos P, van Goor H, Faber KN, Harmsen HJM, Dijkstra G. Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study]. J Crohns Colitis 2020;14:595-607. [PMID: 31873717 DOI: 10.1093/ecco-jcc/jjz208] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
150 Jang SW, Cho MK, Park MK, Kang SA, Na BK, Ahn SC, Kim DH, Yu HS. Parasitic helminth cystatin inhibits DSS-induced intestinal inflammation via IL-10(+)F4/80(+) macrophage recruitment. Korean J Parasitol 2011;49:245-54. [PMID: 22072824 DOI: 10.3347/kjp.2011.49.3.245] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
151 Weber B, Saurer L, Mueller C. Intestinal macrophages: differentiation and involvement in intestinal immunopathologies. Semin Immunopathol. 2009;31:171-184. [PMID: 19533135 DOI: 10.1007/s00281-009-0156-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
152 Roozendaal C, Kallenberg CG. Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)? Clin Exp Immunol. 1999;116:206-213. [PMID: 10337008 DOI: 10.1046/j.1365-2249.1999.00905.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
153 Zaki MH, Lamkanfi M, Kanneganti TD. The Nlrp3 inflammasome: contributions to intestinal homeostasis. Trends Immunol. 2011;32:171-179. [PMID: 21388882 DOI: 10.1016/j.it.2011.02.002] [Cited by in Crossref: 163] [Cited by in F6Publishing: 161] [Article Influence: 14.8] [Reference Citation Analysis]
154 Sturm A, Rilling K, Baumgart DC, Gargas K, Abou-Ghazalé T, Raupach B, Eckert J, Schumann RR, Enders C, Sonnenborn U. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Infect Immun. 2005;73:1452-1465. [PMID: 15731043 DOI: 10.1128/iai.73.3.1452-1465.2005] [Cited by in Crossref: 84] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
155 Zurita-Turk M, Mendes Souza B, Prósperi de Castro C, Bastos Pereira V, Pecini da Cunha V, Melo Preisser T, Caetano de Faria AM, Carmona Cara Machado D, Miyoshi A. Attenuation of intestinal inflammation in IL-10 deficient mice by a plasmid carrying Lactococcus lactis strain. BMC Biotechnol 2020;20:38. [PMID: 32703192 DOI: 10.1186/s12896-020-00631-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
156 Chen L, Lin MJ, Zhan LL, Lv XP. Analysis of TLR4 and TLR2 polymorphisms in inflammatory bowel disease in a Guangxi Zhuang population. World J Gastroenterol 2012; 18(46): 6856-6860 [PMID: 23239925 DOI: 10.3748/wjg.v18.i46.6856] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
157 Zhou Y, Zhu Y, Jiang H, Chen Z, Lu B, Li J, Shen X. Polymorphism rs6478109 in the TNFSF15 gene contributes to the susceptibility to Crohn's disease but not ulcerative colitis: a meta-analysis. J Int Med Res 2020;48:300060520961675. [PMID: 33026276 DOI: 10.1177/0300060520961675] [Reference Citation Analysis]
158 Cronin J, Moore S, Lenihan N, O'Shea M, Woods N. The non-drug costs associated with the administration of an intravenous biologic treatment in the hospital setting. Ir J Med Sci 2019;188:821-34. [PMID: 30467804 DOI: 10.1007/s11845-018-1925-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
159 Zackular JP, Skaar EP. The role of zinc and nutritional immunity in Clostridium difficile infection. Gut Microbes 2018;9:469-76. [PMID: 29533126 DOI: 10.1080/19490976.2018.1448354] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
160 Ko IK, Kim BG, Awadallah A, Mikulan J, Lin P, Letterio JJ, Dennis JE. Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther. 2010;18:1365-1372. [PMID: 20389289 DOI: 10.1038/mt.2010.54] [Cited by in Crossref: 122] [Cited by in F6Publishing: 117] [Article Influence: 10.2] [Reference Citation Analysis]
161 Suárez J, Romero-Zerbo Y, Márquez L, Rivera P, Iglesias M, Bermúdez-Silva FJ, Andreu M, Rodríguez de Fonseca F. Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids. PLoS One 2012;7:e37729. [PMID: 22662201 DOI: 10.1371/journal.pone.0037729] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
162 Zhou J, O'Keeffe M, Liao G, Zhao F, Terhorst C, Xu B. Design and Synthesis of Nanofibers of Self-assembled de novo Glycoconjugates towards Mucosal Lining Restoration and Anti-Inflammatory Drug Delivery. Tetrahedron 2016;72:6078-83. [PMID: 28216796 DOI: 10.1016/j.tet.2016.07.057] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
163 Caviglia R, Ribolsi M, Rizzi M, Emerenziani S, Annunziata ML, Cicala M. Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up. World J Gastroenterol 2007; 13(39): 5238-5244 [PMID: 17876895 DOI: 10.3748/wjg.v13.i39.5238] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
164 Sureshkumar S, Jung SK, Kim D, Oh KB, Yang H, Lee HC, Jin JY, Sun LH, Lee S, Byun SJ. Oral administration of Lactobacillus reuteri expressing a 3D8 single-chain variable fragment (scFv) enhances chicken growth and conserves immune homeostasis. 3 Biotech 2019;9:282. [PMID: 31245246 DOI: 10.1007/s13205-019-1811-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
165 Gironella M, Iovanna JL, Sans M, Gil F, Peñalva M, Closa D, Miquel R, Piqué JM, Panés J. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease. Gut 2005;54:1244-53. [PMID: 15870231 DOI: 10.1136/gut.2004.056309] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 4.5] [Reference Citation Analysis]
166 Rampton DS. Management of Crohn's disease. BMJ. 1999;319:1480-1485. [PMID: 10582935 DOI: 10.1136/bmj.319.7223.1480] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
167 Sun H, Lou Y, Porturas T, Morrissey S, Luo G, Qi J, Ruan Q, Shi S, Chen YH. Exacerbated experimental colitis in TNFAIP8-deficient mice. J Immunol 2015;194:5736-42. [PMID: 25948814 DOI: 10.4049/jimmunol.1401986] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
168 Al-Mofarreh MA, Al-Mofleh IA. Emerging inflammatory bowel disease in saudi outpatients: a report of 693 cases. Saudi J Gastroenterol. 2013;19:16-22. [PMID: 23319033 DOI: 10.4103/1319-3767.105915] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
169 Monteleone I, Vavassori P, Biancone L, Monteleone G, Pallone F. Immunoregulation in the gut: success and failures in human disease. Gut. 2002;50 Suppl 3:III60-III64. [PMID: 11953335 DOI: 10.1136/gut.50.suppl_3.iii60] [Cited by in Crossref: 47] [Cited by in F6Publishing: 67] [Article Influence: 2.4] [Reference Citation Analysis]
170 Sari S, Egritas O, Dalgic B. The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy. Eur J Pediatr. 2008;167:391-393. [PMID: 17520284 DOI: 10.1007/s00431-007-0508-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
171 Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Alterations in the function of circulating mononuclear cells derived from patients with Crohn’s disease treated with mastic. World J Gastroenterol 2007; 13(45): 6031-6036 [DOI: 10.3748/wjg.v13.i45.6031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
172 Shimamoto M, Ueno Y, Tanaka S, Onitake T, Hanaoka R, Yoshioka K, Hatakeyama T, Chayama K. Selective decrease in colonic CD56(+) T and CD161(+) T cells in the inflamed mucosa of patients with ulcerative colitis. World J Gastroenterol 2007;13:5995-6002. [PMID: 18023089 DOI: 10.3748/wjg.v13.45.5995] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
173 Kazi HA, Qian Z. Crocetin reduces TNBS-induced experimental colitis in mice by downregulation of NFkB. Saudi J Gastroenterol 2009;15:181-7. [PMID: 19636180 DOI: 10.4103/1319-3767.54750] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
174 McNamee EN, Rivera-Nieves J. Ectopic Tertiary Lymphoid Tissue in Inflammatory Bowel Disease: Protective or Provocateur? Front Immunol. 2016;7:308. [PMID: 27579025 DOI: 10.3389/fimmu.2016.00308] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
175 Rivera-Nieves J, Burcin TL, Olson TS, Morris MA, McDuffie M, Cominelli F, Ley K. Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis. J Exp Med. 2006;203:907-917. [PMID: 16567389 DOI: 10.1084/jem.20052530] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 4.2] [Reference Citation Analysis]
176 Taha AS, Grant V, Kelly RW. Urinalysis for interleukin-8 in the non-invasive diagnosis of acute and chronic inflammatory diseases. Postgrad Med J 2003;79:159-63. [PMID: 12697917 DOI: 10.1136/pmj.79.929.159] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
177 Eijkelkamp N, Heijnen CJ, Lucas A, Premont RT, Elsenbruch S, Schedlowski M, Kavelaars A. G protein-coupled receptor kinase 6 controls chronicity and severity of dextran sodium sulphate-induced colitis in mice. Gut. 2007;56:847-854. [PMID: 17229795 DOI: 10.1136/gut.2006.107094] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
178 Liu X, Wang JM. Iridoid glycosides fraction of Folium syringae leaves modulates NF-κB signal pathway and intestinal epithelial cells apoptosis in experimental colitis. PLoS One. 2011;6:e24740. [PMID: 21931839 DOI: 10.1371/journal.pone.0024740] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
179 Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005;43:3380-3389. [PMID: 16000463 DOI: 10.1128/jcm.43.7.3380-3389.2005] [Cited by in Crossref: 540] [Cited by in F6Publishing: 302] [Article Influence: 31.8] [Reference Citation Analysis]
180 Majumdar D, Tiernan JP, Lobo AJ, Evans CA, Corfe BM. Keratins in colorectal epithelial function and disease. Int J Exp Pathol 2012;93:305-18. [PMID: 22974212 DOI: 10.1111/j.1365-2613.2012.00830.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
181 Sturm A, Leite AZ, Danese S, Krivacic KA, West GA, Mohr S, Jacobberger JW, Fiocchi C. Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn’s disease and ulcerative colitis. Gut. 2004;53:1624-1631. [PMID: 15479683 DOI: 10.1136/gut.2003.033613] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 3.2] [Reference Citation Analysis]
182 de Silva S, Devlin S, Panaccione R. Optimizing the safety of biologic therapy for IBD. Nat Rev Gastroenterol Hepatol 2010;7:93-101. [PMID: 20134491 DOI: 10.1038/nrgastro.2009.221] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
183 Mueller C. Tumour necrosis factor in mouse models of chronic intestinal inflammation. Immunology 2002;105:1-8. [PMID: 11849309 DOI: 10.1046/j.1365-2567.2002.01329.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
184 Clements JD, Dieleman LA, Arends A, Tonkonogy SL, Goerres MS, Craft DW, Grenther W, Sellon RK, Balish E, Sartor RB. Helicobacter hepaticus Does Not Induce or Potentiate Colitis in Interleukin-10-Deficient Mice. Infect Immun 2000;68:5107-13. [DOI: 10.1128/iai.68.9.5107-5113.2000] [Cited by in Crossref: 94] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
185 Hozumi H, Hokari R, Kurihara C, Narimatsu K, Sato H, Sato S, Ueda T, Higashiyama M, Okada Y, Watanabe C, Komoto S, Tomita K, Kawaguchi A, Nagao S, Miura S. Endoscopic finding of spontaneous hemorrhage correlates with tumor necrosis factor alpha expression in colonic mucosa of patients with ulcerative colitis. Int J Colorectal Dis 2013;28:1049-55. [PMID: 23377880 DOI: 10.1007/s00384-013-1654-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
186 Abdelmegid AM, Abdo FK, Ahmed FE, Kattaia AAA. Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression. Sci Rep 2019;9:10176. [PMID: 31308463 DOI: 10.1038/s41598-019-46671-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
187 Maroni L, van de Graaf SF, Hohenester SD, Oude Elferink RP, Beuers U. Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review. Clin Rev Allergy Immunol 2015;48:182-91. [PMID: 24828903 DOI: 10.1007/s12016-014-8423-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
188 Kazemi-Shirazi L, Gasche CH, Natter S, Gangl A, Smolen J, Spitzauer S, Valent P, Kraft D, Valenta R. IgA autoreactivity: a feature common to inflammatory bowel and connective tissue diseases. Clin Exp Immunol 2002;128:102-9. [PMID: 11982597 DOI: 10.1046/j.1365-2249.2002.01804.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
189 Singh UP, Singh S, Singh R, Cong Y, Taub DD, Lillard JW. CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition. J Interferon Cytokine Res. 2008;28:31-43. [PMID: 18370870 DOI: 10.1089/jir.2007.0059] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
190 Matsuoka K, Inoue N, Sato T, Okamoto S, Hisamatsu T, Kishi Y, Sakuraba A, Hitotsumatsu O, Ogata H, Koganei K, Fukushima T, Kanai T, Watanabe M, Ishii H, Hibi T. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut. 2004;53:1303-1308. [PMID: 15306590 DOI: 10.1136/gut.2003.024190] [Cited by in Crossref: 97] [Cited by in F6Publishing: 94] [Article Influence: 5.4] [Reference Citation Analysis]
191 Al-Mofarreh MA, Al Mofleh IA, Al-Teimi IN, Al-Jebreen AM. Crohn's disease in a Saudi outpatient population: is it still rare? Saudi J Gastroenterol 2009;15:111-6. [PMID: 19568575 DOI: 10.4103/1319-3767.45357] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
192 Li N, Mao J, Tang H, Zhu L, Tan X, Bi J, Wu H, Chen X, Wang Y. Efficacy and safety of adsorptive granulomonocytapheresis in Chinese patients with ulcerative colitis: A retrospective analysis of 50 cases with focus on factors impacting clinical efficacy. J Clin Apher 2020;35:271-80. [PMID: 32378240 DOI: 10.1002/jca.21787] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Lee JH, Regmi SC, Kim JA, Cho MH, Yun H, Lee CS, Lee J. Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect Immun 2011;79:4819-27. [PMID: 21930760 DOI: 10.1128/IAI.05580-11] [Cited by in Crossref: 113] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
194 Wittig BM, Zeitz M. Critical comment: analyzing the effect of novel therapies on cytokine expression in inflammatory bowel disease: do cytokine levels reflect clinical response? Int J Colorectal Dis. 2006;21:505-507. [PMID: 16416269 DOI: 10.1007/s00384-005-0082-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
195 De Vry CG, Prasad S, Komuves L, Lorenzana C, Parham C, Le T, Adda S, Hoffman J, Kahoud N, Garlapati R. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis. Gut. 2007;56:524-533. [PMID: 16950831 DOI: 10.1136/gut.2006.096487] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
196 Duff W, Haskey N, Potter G, Alcorn J, Hunter P, Fowler S. Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance. World J Gastroenterol 2018; 24(28): 3055-3070 [PMID: 30065553 DOI: 10.3748/wjg.v24.i28.3055] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
197 Dombrowicz D, Nutten S, Desreumaux P, Neut C, Torpier G, Peeters M, Colombel JF, Capron M. Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation. J Exp Med 2001;193:25-34. [PMID: 11136818 DOI: 10.1084/jem.193.1.25] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
198 Chamouard P, Desprez D, Hugel B, Kunzelmann C, Gidon-jeangirard C, Lessard M, Baumann R, Freyssinet J, Grunebaum L. Circulating Cell-Derived Microparticles in Crohn?s Disease. Dig Dis Sci 2005;50:574-80. [DOI: 10.1007/s10620-005-2477-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 1.8] [Reference Citation Analysis]
199 Hasegawa A, Iwamura C, Kitajima M, Hashimoto K, Otsuyama K, Ogino H, Nakayama T, Shirai M. Crucial role for CD69 in the pathogenesis of dextran sulphate sodium-induced colitis. PLoS One 2013;8:e65494. [PMID: 23785429 DOI: 10.1371/journal.pone.0065494] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
200 Ruyssers NE, De Winter BY, De Man JG, Loukas A, Herman AG, Pelckmans PA, Moreels TG. Worms and the treatment of inflammatory bowel disease: are molecules the answer? Clin Dev Immunol 2008;2008:567314. [PMID: 18509490 DOI: 10.1155/2008/567314] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
201 Qualtrough D, Smallwood K, Littlejohns D, Pignatelli M. The actin-bundling protein fascin is overexpressed in inflammatory bowel disease and may be important in tissue repair. BMC Gastroenterol 2011;11:14. [PMID: 21345224 DOI: 10.1186/1471-230X-11-14] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
202 Hanai H, Iida T, Yamada M, Sato Y, Takeuchi K, Tanaka T, Kondo K, Kikuyama M, Maruyama Y, Iwaoka Y, Nakamura A, Hirayama K, Saniabadi AR, Watanabe F. Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis. World J Gastroenterol 2006; 12(21): 3393-3399 [PMID: 16733857 DOI: 10.3748/wjg.v12.i21.3393] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
203 Grémy O, Benderitter M, Linard C. Caffeic acid phenethyl ester modifies the Th1/Th2 balance in ileal mucosa after γ-irradiation in the rat by modulating the cytokine pattern. World J Gastroenterol 2006; 12(31): 4996-5004 [PMID: 16937495 DOI: 10.3748/wjg.v12.i31.4996] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
204 Neudecker V, Haneklaus M, Jensen O, Khailova L, Masterson JC, Tye H, Biette K, Jedlicka P, Brodsky KS, Gerich ME, Mack M, Robertson AAB, Cooper MA, Furuta GT, Dinarello CA, O'Neill LA, Eltzschig HK, Masters SL, McNamee EN. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017;214:1737-1752. [PMID: 28487310 DOI: 10.1084/jem.20160462] [Cited by in Crossref: 168] [Cited by in F6Publishing: 167] [Article Influence: 33.6] [Reference Citation Analysis]
205 Yanaba K, Yoshizaki A, Asano Y, Kadono T, Tedder TF, Sato S. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol. 2011;178:735-743. [PMID: 21281806 DOI: 10.1016/j.ajpath.2010.10.022] [Cited by in Crossref: 126] [Cited by in F6Publishing: 117] [Article Influence: 11.5] [Reference Citation Analysis]
206 Shaoul R, Karban A, Reif S, Weiss B, Shamir R, Tamir A, Davidovich O, Halevi J, Silver EL, Levine A. Disease behavior in children with Crohn’s disease: the effect of disease duration, ethnicity, genotype, and phenotype. Dig Dis Sci. 2009;54:142-150. [PMID: 18594982 DOI: 10.1007/s10620-008-0326-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
207 Barton SG, Rampton DS, Winrow VR, Domizio P, Feakins RM. Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones. 2003;8:329-334. [PMID: 15115285 DOI: 10.1379/1466-1268(2003)008<0329] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
208 Liu M, Boussetta T, Makni-Maalej K, Fay M, Driss F, El-Benna J, Lagarde M, Guichardant M. Protectin DX, a double lipoxygenase product of DHA, inhibits both ROS production in human neutrophils and cyclooxygenase activities. Lipids 2014;49:49-57. [PMID: 24254970 DOI: 10.1007/s11745-013-3863-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
209 Diezmos EF, Bertrand PP, Liu L. Purinergic Signaling in Gut Inflammation: The Role of Connexins and Pannexins. Front Neurosci 2016;10:311. [PMID: 27445679 DOI: 10.3389/fnins.2016.00311] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
210 Morohashi T, Iwabuchi K, Watano K, Dashtsoodol N, Mishima T, Nakai Y, Shimada S, Nishida R, Fujii S, Onoé K. Allograft inflammatory factor-1 regulates trinitrobenzene sulphonic acid-induced colitis. Immunology 2003;110:112-9. [PMID: 12941148 DOI: 10.1046/j.1365-2567.2003.01714.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
211 Rieder F, Brenmoehl J, Leeb S, Schölmerich J, Rogler G. Wound healing and fibrosis in intestinal disease. Gut 2007;56:130-9. [PMID: 17172588 DOI: 10.1136/gut.2006.090456] [Cited by in Crossref: 194] [Cited by in F6Publishing: 185] [Article Influence: 12.9] [Reference Citation Analysis]
212 Dodda D, Chhajed R, Mishra J, Padhy M. Targeting oxidative stress attenuates trinitrobenzene sulphonic acid induced inflammatory bowel disease like symptoms in rats: role of quercetin. Indian J Pharmacol. 2014;46:286-291. [PMID: 24987175 DOI: 10.4103/0253-7613.132160] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
213 He Q, Wang L, Wang F, Wang C, Tang C, Li Q, Li J, Zhao Q. Microbial fingerprinting detects intestinal microbiota dysbiosis in zebrafish models with chemically-induced enterocolitis. BMC Microbiology. 2013;13:289. [PMID: 24325678 DOI: 10.1186/1471-2180-13-289] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
214 Okada Y, Maeda N, Takakura S, Miyata K, Koshiba M. Preventive and therapeutic effects of tacrolimus in an interleukin-10-deficient mouse model of colitis. Inflamm Res 2011;60:1049-59. [PMID: 21830095 DOI: 10.1007/s00011-011-0366-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
215 Nicchitta CV. Come forth CD1d: Hsp110 in the regulation of intestinal epithelial CD1d expression. J Clin Invest 2003;112:646-8. [PMID: 12952910 DOI: 10.1172/JCI19641] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
216 Pawar P, Gilda S, Sharma S, Jagtap S, Paradkar A, Mahadik K, Ranjekar P, Harsulkar A. Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced inflammatory bowel disease. BMC Complement Altern Med 2011;11:34. [PMID: 21527003 DOI: 10.1186/1472-6882-11-34] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
217 Doering J, Begue B, Lentze MJ, Rieux-Laucat F, Goulet O, Schmitz J, Cerf-Bensussan N, Ruemmele FM. Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease. Gut 2004;53:1632-8. [PMID: 15479684 DOI: 10.1136/gut.2003.037911] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 3.6] [Reference Citation Analysis]
218 Peng Y, Tellier LE, Temenoff JS. Heparin-based hydrogels with tunable sulfation & degradation for anti-inflammatory small molecule delivery. Biomater Sci 2016;4:1371-80. [PMID: 27447003 DOI: 10.1039/c6bm00455e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
219 Videla S, Lugea A, Vilaseca J, Guarner F, Treserra F, Salas A, Crespo E, Medina C, Malagelada JR. Polyethylene glycol enhances colonic barrier function and ameliorates experimental colitis in rats. Int J Colorectal Dis. 2007;22:571-580. [PMID: 17061105 DOI: 10.1007/s00384-006-0232-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
220 Cicchitti L, Martelli M, Cerritelli F. Chronic inflammatory disease and osteopathy: a systematic review. PLoS One 2015;10:e0121327. [PMID: 25781621 DOI: 10.1371/journal.pone.0121327] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
221 Witherden DA, Rieder SE, Boismenu R, Havran WL. A role for epithelial gamma delta T cells in tissue repair. Springer Semin Immunopathol 2000;22:265-81. [PMID: 11116957 DOI: 10.1007/s002810000045] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
222 Smyth CM, Akasheh N, Woods S, Kay E, Morgan RK, Thornton MA, O'Grady A, Cummins R, Sheils O, Smyth P, Gleich GJ, Murray FM, Costello RW. Activated eosinophils in association with enteric nerves in inflammatory bowel disease. PLoS One 2013;8:e64216. [PMID: 23717571 DOI: 10.1371/journal.pone.0064216] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
223 Kim MJ, Lee WY, Choe YH. Expression of TIM-3, Human β-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy. Gut Liver 2015;9:370-80. [PMID: 25071071 DOI: 10.5009/gnl13408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
224 Selmeczy Z, Csóka B, Pacher P, Vizi ES, Haskó G. The adenosine A2A receptor agonist CGS 21680 fails to ameliorate the course of dextran sulphate-induced colitis in mice. Inflamm Res 2007;56:204-9. [PMID: 17588136 DOI: 10.1007/s00011-006-6150-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
225 Miao XP, Ouyang Q, Li HY, Wen ZH, Zhang DK, Cui XY. Role of selective cyclooxygenase-2 inhibitors in exacerbation of inflammatory bowel disease: A systematic review and meta-analysis. Curr Ther Res Clin Exp 2008;69:181-91. [PMID: 24692797 DOI: 10.1016/j.curtheres.2008.06.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
226 Billerey-Larmonier C, Uno JK, Larmonier N, Midura AJ, Timmermann B, Ghishan FK, Kiela PR. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis 2008;14:780-93. [PMID: 18200517 DOI: 10.1002/ibd.20348] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
227 St-Pierre J, Chadee K. How the discovery of TNF-α has advanced gastrointestinal diseases and treatment regimes. Dig Dis Sci 2014;59:712-5. [PMID: 24504593 DOI: 10.1007/s10620-014-3042-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
228 Motavallian A, Minaiyan M, Rabbani M, Andalib S, Mahzouni P. Involvement of 5HT3 Receptors in Anti-Inflammatory Effects of Tropisetron on Experimental TNBS-Induced Colitis in Rat. Bioimpacts. 2013;3:169-176. [PMID: 24455480 DOI: 10.5681/bi.2013.021] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
229 Javed NH, Alsahly MB, Khubchandani J. Oral Feeding of Probiotic Bifidobacterium infantis: Colonic Morphological Changes in Rat Model of TNBS-Induced Colitis. Scientifica (Cairo) 2016;2016:9572596. [PMID: 27127686 DOI: 10.1155/2016/9572596] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
230 Nahidi L, Leach ST, Lemberg DA, Day AS. Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation. Dig Dis Sci. 2013;58:3144-3155. [PMID: 24048682 DOI: 10.1007/s10620-013-2851-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
231 Sica GS, Iaculli E, Benavoli D, Biancone L, Calabrese E, Onali S, Gaspari AL. Laparoscopic versus open ileo-colonic resection in Crohn’s disease: short- and long-term results from a prospective longitudinal study. J Gastrointest Surg. 2008;12:1094-1102. [PMID: 18027061 DOI: 10.1007/s1165-007-0394-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
232 Li C, Dandridge KS, Di A, Marrs KL, Harris EL, Roy K, Jackson JS, Makarova NV, Fujiwara Y, Farrar PL. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J Exp Med. 2005;202:975-986. [PMID: 16203867 DOI: 10.1084/jem.20050421] [Cited by in Crossref: 119] [Cited by in F6Publishing: 114] [Article Influence: 7.4] [Reference Citation Analysis]
233 Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, El Yafi F, Colombel JF, Belaiche J. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut. 2003;52:552-557. [PMID: 12631668 DOI: 10.1136/gut.52.4.552] [Cited by in Crossref: 181] [Cited by in F6Publishing: 174] [Article Influence: 9.5] [Reference Citation Analysis]
234 Singh UP, Singh R, Singh S, Karls RK, Quinn FD, Taub DD, Lillard JW Jr. CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis. BMC Immunol 2008;9:25. [PMID: 18533024 DOI: 10.1186/1471-2172-9-25] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
235 Shi Y, Rupa P, Jiang B, Mine Y. Hydrolysate from eggshell membrane ameliorates intestinal inflammation in mice. Int J Mol Sci 2014;15:22728-42. [PMID: 25501329 DOI: 10.3390/ijms151222728] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
236 Scaldaferri F, Sans M, Vetrano S, Graziani C, De Cristofaro R, Gerlitz B, Repici A, Arena V, Malesci A, Panes J. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest. 2007;117:1951-1960. [PMID: 17557119 DOI: 10.1172/jci31027] [Cited by in Crossref: 85] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
237 Assas MB, Levison S, Pennock JL. Early induction of C/EBPβ expression as a potential marker of steroid responsive colitis. Sci Rep 2019;9:13087. [PMID: 31511552 DOI: 10.1038/s41598-019-48251-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
238 Ben Alaya W, Sfar I, Aouadi H, Jendoubi S, Najjar T, Filali A, Gorgi Y, Ben Abdallah T, Mouelhi L, Matri S. Association between CTLA-4 gene promoter (49 A/G) in exon 1 polymorphisms and inflammatory bowel disease in the Tunisian population. Saudi J Gastroenterol. 2009;15:29-34. [PMID: 19568552 DOI: 10.4103/1319-3767.43285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
239 Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol. 2002;160:2253-2257. [PMID: 12057927 DOI: 10.1016/s0002-9440(10)61172-8] [Cited by in Crossref: 215] [Cited by in F6Publishing: 106] [Article Influence: 10.8] [Reference Citation Analysis]
240 Pena Rossi C, Hanauer SB, Tomasevic R, Hunter JO, Shafran I, Graffner H. Interferon beta-1a for the maintenance of remission in patients with Crohn’s disease: results of a phase II dose-finding study. BMC Gastroenterol. 2009;9:22. [PMID: 19302707 DOI: 10.1186/1471-230x-9-22] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
241 Takahashi M, Nakamura K, Honda K, Kitamura Y, Mizutani T, Araki Y, Kabemura T, Chijiiwa Y, Harada N, Nawata H. An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis. Dig Dis Sci. 2006;51:677-686. [PMID: 16614988 DOI: 10.1007/s10620-006-3191-2] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 4.1] [Reference Citation Analysis]
242 Baird AC, Lloyd F, Lawrance IC. Prostaglandin E₂ and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function. Dig Dis Sci 2015;60:1603-16. [PMID: 25630423 DOI: 10.1007/s10620-015-3552-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
243 Saunders PR, Santos J, Hanssen NP, Yates D, Groot JA, Perdue MH. Physical and psychological stress in rats enhances colonic epithelial permeability via peripheral CRH. Dig Dis Sci. 2002;47:208-215. [PMID: 11852879 DOI: 10.1023/a:1013204612762] [Cited by in Crossref: 122] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
244 Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci USA. 2010;107:454-459. [PMID: 20018654 DOI: 10.1073/pnas.0910307107] [Cited by in Crossref: 218] [Cited by in F6Publishing: 211] [Article Influence: 16.8] [Reference Citation Analysis]
245 Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Diaz-Ropero MP, Olivares M, Xaus J, Zarzuelo A, Galvez J. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J Gastroenterol 2005; 11(33): 5185-5192 [PMID: 16127750 DOI: 10.3748/wjg.v11.i33.5185] [Cited by in F6Publishing: 43] [Reference Citation Analysis]
246 Hanada T, Kobayashi T, Chinen T, Saeki K, Takaki H, Koga K, Minoda Y, Sanada T, Yoshioka T, Mimata H. IFNgamma-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. J Exp Med. 2006;203:1391-1397. [PMID: 16717119 DOI: 10.1084/jem.20060436] [Cited by in Crossref: 128] [Cited by in F6Publishing: 123] [Article Influence: 8.0] [Reference Citation Analysis]
247 Uddin MJ, Jeong SO, Zheng M, Chen Y, Cho GJ, Chung HT, Joe Y. Carbon monoxide attenuates dextran sulfate sodium-induced colitis via inhibition of GSK-3β signaling. Oxid Med Cell Longev. 2013;2013:210563. [PMID: 24349609 DOI: 10.1155/2013/210563] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
248 Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010;32:379-91. [PMID: 20303296 DOI: 10.1016/j.immuni.2010.03.003] [Cited by in Crossref: 593] [Cited by in F6Publishing: 587] [Article Influence: 49.4] [Reference Citation Analysis]
249 Tsay TB, Chang CJ, Chen PH, Hsu CM, Chen LW. Nod2 mutation enhances NF-kappa B activity and bacterial killing activity of macrophages. Inflammation 2009;32:372-8. [PMID: 19728064 DOI: 10.1007/s10753-009-9145-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
250 Fiocchi C. Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis? Autoimmunity Reviews 2004;3:574-5. [DOI: 10.1016/j.autrev.2004.07.020] [Reference Citation Analysis]
251 Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg. 2006;391:499-510. [PMID: 16909291 DOI: 10.1007/s00423-006-0073-1] [Cited by in Crossref: 296] [Cited by in F6Publishing: 270] [Article Influence: 18.5] [Reference Citation Analysis]
252 Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M. Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn’s disease. Gut. 2006;55:824-832. [PMID: 16401687 DOI: 10.1136/gut.2005.084525] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 4.7] [Reference Citation Analysis]
253 Cengiz D, Gürçay E, Karaahmet ÖZ, Karaahmet F, Umay E, Çakcı A. Inflammatory arthritis complicated by inflammatory bowel disease: two case reports. Turk J Phys Med Rehabil 2017;63:266-71. [PMID: 31453464 DOI: 10.5606/tftrd.2017.23169] [Reference Citation Analysis]
254 Chan SN, Low END, Raja Ali RA, Mokhtar NM. Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence. Intest Res 2018;16:374-83. [PMID: 30090036 DOI: 10.5217/ir.2018.16.3.374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
255 Ben Aleya W, Sfar I, Mouelhi L, Aouadi H, Makhlouf M, Ayed-Jendoubi S, Matri S, Filali A, Najjar T, Ben Abdallah T, Ayed K, Gorgi Y. Association of Fas/Apo1 gene promoter (-670 A/G) polymorphism in Tunisian patients with IBD. World J Gastroenterol 2009; 15(29): 3643-3648 [PMID: 19653342 DOI: 10.3748/wjg.15.3643] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
256 Ono K, Nimura S, Nishinakagawa T, Hideshima Y, Enjyoji M, Nabeshima K, Nakashima M. Sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium-induced colitis in mice. Exp Ther Med 2014;7:573-8. [PMID: 24520247 DOI: 10.3892/etm.2013.1456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
257 Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann RR. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun. 2006;74:4075-4082. [PMID: 16790781 DOI: 10.1128/iai.01449-05] [Cited by in Crossref: 124] [Cited by in F6Publishing: 63] [Article Influence: 7.8] [Reference Citation Analysis]
258 Kanaan ZM, Eichenberger MR, Ahmad S, Weller C, Roberts H, Pan J, Rai SN, Petras R, Weller EB Jr, Galandiuk S. Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population. J Negat Results Biomed 2012;11:7. [PMID: 22269043 DOI: 10.1186/1477-5751-11-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
259 Maisel K, Ensign L, Reddy M, Cone R, Hanes J. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. J Control Release. 2015;197:48-57. [PMID: 25449804 DOI: 10.1016/j.jconrel.2014.10.026] [Cited by in Crossref: 193] [Cited by in F6Publishing: 179] [Article Influence: 24.1] [Reference Citation Analysis]
260 Wittig BM, Johansson B, Zöller M, Schwärzler C, Günthert U. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J Exp Med 2000;191:2053-64. [PMID: 10859330 DOI: 10.1084/jem.191.12.2053] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 3.5] [Reference Citation Analysis]
261 Mo JS, Han SH, Yun KJ, Chae SC. MicroRNA 429 regulates the expression of CHMP5 in the inflammatory colitis and colorectal cancer cells. Inflamm Res. 2018;67:985-996. [PMID: 30334065 DOI: 10.1007/s00011-018-1194-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
262 Diefenbach KA, Breuer CK. Pediatric inflammatory bowel disease. World J Gastroenterol 2006; 12(20): 3204-3212 [PMID: 16718840 DOI: 10.3748/wjg.v12.i20.3204] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
263 Narumiya S. Physiology and pathophysiology of prostanoid receptors. Proc Jpn Acad Ser B Phys Biol Sci 2007;83:296-319. [PMID: 24367153 DOI: 10.2183/pjab/83.296] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
264 Chen T, Isomäki P, Rimpiläinen M, Toivanen P. Human cytokine responses induced by gram-positive cell walls of normal intestinal microbiota. Clin Exp Immunol 1999;118:261-7. [PMID: 10540188 DOI: 10.1046/j.1365-2249.1999.01047.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 1.6] [Reference Citation Analysis]
265 Matsuzaki K, Tsuzuki Y, Matsunaga H, Inoue T, Miyazaki J, Hokari R, Okada Y, Kawaguchi A, Nagao S, Itoh K. In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. Clin Exp Immunol. 2005;140:22-31. [PMID: 15762871 DOI: 10.1111/j.1365-2249.2005.02742.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
266 Homsak E, Micetić-Turk D, Bozic B. Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value. Wien Klin Wochenschr 2010;122 Suppl 2:19-25. [PMID: 20517666 DOI: 10.1007/s00508-010-1344-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
267 De Simone M, Cioffi U, Contessini-Avesani E, Oreggia B, Paliotti R, Pierini A, Bolla G, Oggiano E, Ferrero S, Magrini F, Ciulla MM. Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgery. BMC Gastroenterol 2004;4:29. [PMID: 15527511 DOI: 10.1186/1471-230X-4-29] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
268 Boussetta T, Raad H, Lettéron P, Gougerot-Pocidalo MA, Marie JC, Driss F, El-Benna J. Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats. PLoS One. 2009;4:e6458. [PMID: 19649246 DOI: 10.1371/journal.pone.0006458] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 5.7] [Reference Citation Analysis]
269 Helwig U, Lammers KM, Rizzello F, Brigidi P, Rohleder V, Caramelli E, Gionchetti P, Schrezenmeir J, Foelsch UR, Schreiber S, Campieri M. Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol 2006; 12(37): 5978-5986 [PMID: 17009396 DOI: 10.3748/wjg.v12.i37.5978] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 77] [Article Influence: 5.0] [Reference Citation Analysis]
270 Zahn A, Moehle C, Langmann T, Ehehalt R, Autschbach F, Stremmel W, Schmitz G. Aquaporin-8 expression is reduced in ileum and induced in colon of patients with ulcerative colitis. World J Gastroenterol 2007; 13(11): 1687-1695 [PMID: 17461471 DOI: 10.3748/wjg.v13.i11.1687] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
271 Yoshihara K, Yajima T, Kubo C, Yoshikai Y. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut. 2006;55:334-341. [PMID: 16162679 DOI: 10.1136/gut.2005.076000] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 3.9] [Reference Citation Analysis]
272 Azer SA, Azer S. What can we learn from top-cited articles in inflammatory bowel disease? A bibliometric analysis and assessment of the level of evidence. BMJ Open. 2018;8:e021233. [PMID: 30002009 DOI: 10.1136/bmjopen-2017-021233] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
273 Irwin R, Raehtz S, Parameswaran N, McCabe LR. Intestinal inflammation without weight loss decreases bone density and growth. Am J Physiol Regul Integr Comp Physiol 2016;311:R1149-57. [PMID: 27733383 DOI: 10.1152/ajpregu.00051.2016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
274 Kushkevych I, Castro Sangrador J, Dordević D, Rozehnalová M, Černý M, Fafula R, Vítězová M, Rittmann SKR. Evaluation of Physiological Parameters of Intestinal Sulfate-Reducing Bacteria Isolated from Patients Suffering from IBD and Healthy People. J Clin Med 2020;9:E1920. [PMID: 32575467 DOI: 10.3390/jcm9061920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
275 de la Concha EG, Fernandez-Arquero M, Martinez A, Vigil P, Vidal F, Lopez-Nava G, Diaz-Rubio M, Garcia-Paredes J. Amino acid polymorphism at residue 71 in HLA-DR beta chain plays a critical role in susceptibility to ulcerative colitis. Dig Dis Sci. 1999;44:2324-2329. [PMID: 10573382 DOI: 10.1023/a:1026629409481] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
276 Milia AF, Manetti M, Generini S, Polidori L, Benelli G, Cinelli M, Messerini L, Ibba-Manneschi L, Matucci-Cerinic M. TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats. J Cell Mol Med. 2009;13:164-176. [PMID: 18363845 DOI: 10.1111/j.1582-4934.2008.00310.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
277 Decara J, Rivera P, López-Gambero AJ, Serrano A, Pavón FJ, Baixeras E, Rodríguez de Fonseca F, Suárez J. Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases. Front Pharmacol 2020;11:730. [PMID: 32536865 DOI: 10.3389/fphar.2020.00730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
278 Wang X, Jiang Y, Zhu Y, Zhang M, Li M, Wang H, Gao P. Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis. J Cell Mol Med 2016;20:804-14. [PMID: 26800315 DOI: 10.1111/jcmm.12728] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
279 Brandt E, Colombel JF, Ectors N, Gambiez L, Emilie D, Geboes K, Capron M, Desreumaux P. Enhanced production of IL-8 in chronic but not in early ileal lesions of Crohn's disease (CD). Clin Exp Immunol 2000;122:180-5. [PMID: 11091272 DOI: 10.1046/j.1365-2249.2000.01364.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
280 Vezza T, Rodríguez-nogales A, Algieri F, Utrilla M, Rodriguez-cabezas M, Galvez J. Flavonoids in Inflammatory Bowel Disease: A Review. Nutrients 2016;8:211. [DOI: 10.3390/nu8040211] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 18.8] [Reference Citation Analysis]
281 Treede I, Braun A, Sparla R, Kühnel M, Giese T, Turner JR, Anes E, Kulaksiz H, Füllekrug J, Stremmel W, Griffiths G, Ehehalt R. Anti-inflammatory effects of phosphatidylcholine. J Biol Chem 2007;282:27155-64. [PMID: 17636253 DOI: 10.1074/jbc.M704408200] [Cited by in Crossref: 144] [Cited by in F6Publishing: 62] [Article Influence: 9.6] [Reference Citation Analysis]
282 Dou YX, Zhou JT, Wang TT, Huang YF, Chen VP, Xie YL, Lin ZX, Gao JS, Su ZR, Zeng HF. Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis. Int J Nanomedicine 2018;13:5887-907. [PMID: 30319255 DOI: 10.2147/IJN.S174146] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
283 Camuesco D, Comalada M, Rodríguez-Cabezas ME, Nieto A, Lorente MD, Concha A, Zarzuelo A, Gálvez J. The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol 2004;143:908-18. [PMID: 15533892 DOI: 10.1038/sj.bjp.0705941] [Cited by in Crossref: 159] [Cited by in F6Publishing: 157] [Article Influence: 8.8] [Reference Citation Analysis]
284 Yu Q, Zhu S, Zhou R, Yi F, Bing Y, Huang S, Wang Z, Wang C, Xia B. Effects of sinomenine on the expression of microRNA-155 in 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice. PLoS One 2013;8:e73757. [PMID: 24066068 DOI: 10.1371/journal.pone.0073757] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
285 Westendorf AM, Templin M, Geffers R, Deppenmeier S, Gruber AD, Probst-Kepper M, Hansen W, Liblau RS, Gunzer F, Bruder D. CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation. Gut. 2005;54:60-69. [PMID: 15591505 DOI: 10.1136/gut.2003.037663] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
286 Fukata T, Mizushima T, Nishimura J, Okuzaki D, Wu X, Hirose H, Yokoyama Y, Kubota Y, Nagata K, Tsujimura N, Inoue A, Miyoshi N, Haraguchi N, Takahashi H, Hata T, Matsuda C, Kayama H, Takeda K, Doki Y, Mori M, Yamamoto H. The Supercarbonate Apatite-MicroRNA Complex Inhibits Dextran Sodium Sulfate-Induced Colitis. Mol Ther Nucleic Acids 2018;12:658-71. [PMID: 30092402 DOI: 10.1016/j.omtn.2018.07.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
287 Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kikuyama M, Tanaka T, Kondo K, Tanaka K, Takai K. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis. World J Gastroenterol 2005; 11(20): 3085-3090 [PMID: 15918195 DOI: 10.3748/wjg.v11.i20.3085] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
288 Nakamura K, Honda K, Mizutani T, Akiho H, Harada N. Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules. World J Gastroenterol 2006; 12(29): 4628-4635 [PMID: 16937430 DOI: 10.3748/wjg.v12.i29.4628] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 71] [Article Influence: 4.6] [Reference Citation Analysis]
289 Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, Fiocchi C. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003;52:1435-41. [PMID: 12970136 DOI: 10.1136/gut.52.10.1435] [Cited by in Crossref: 164] [Cited by in F6Publishing: 176] [Article Influence: 8.6] [Reference Citation Analysis]
290 Li AC, Thompson RP. Basement membrane components. J Clin Pathol 2003;56:885-7. [PMID: 14645343 DOI: 10.1136/jcp.56.12.885] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
291 Nunes T, Bernardazzi C, de Souza HS. Interleukin-33 and inflammatory bowel diseases: lessons from human studies. Mediators Inflamm. 2014;2014:423957. [PMID: 24701033 DOI: 10.1155/2014/423957] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
292 Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B, Graziadei I, Dunzendorfer S, Wiedermann CJ, Mürzl E. Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol. 2004;24:74-85. [PMID: 14997037 DOI: 10.1023/b: joci.0000018066.46279.6b] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
293 Zhang H, Ouyang Q, Wen ZH, Fiocchi C, Liu WP, Chen DY, Li FY. Significance of glucocorticoid receptor expression in colonic mucosal cells of patients with ulcerative colitis. World J Gastroenterol 2005; 11(12): 1775-1778 [PMID: 15793862 DOI: 10.3748/wjg.v11.i12.1775] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
294 Hogan SP, Rothenberg ME, Forbes E, Smart VE, Matthaei KI, Foster PS. Chemokines in eosinophil-associated gastrointestinal disorders. Curr Allergy Asthma Rep 2004;4:74-82. [PMID: 14680626 DOI: 10.1007/s11882-004-0047-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
295 Ozaki H, Hori M, Kinoshita K, Ohama T. Intestinal dysmotility in inflammatory bowel disease: mechanisms of the reduced activity of smooth muscle contraction. Inflammopharmacology. 2005;13:103-111. [PMID: 16259732 DOI: 10.1163/156856005774423773] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
296 Ardizzone S, Bianchi Porro G. Biologic Therapy for Inflammatory Bowel Disease: . Drugs 2005;65:2253-86. [DOI: 10.2165/00003495-200565160-00002] [Cited by in Crossref: 178] [Cited by in F6Publishing: 178] [Article Influence: 10.5] [Reference Citation Analysis]
297 Schwab M, Klotz U. Pharmacokinetic considerations in the treatment of inflammatory bowel disease. Clin Pharmacokinet. 2001;40:723-751. [PMID: 11707060 DOI: 10.2165/00003088-200140100-00003] [Cited by in Crossref: 96] [Cited by in F6Publishing: 86] [Article Influence: 4.8] [Reference Citation Analysis]
298 Bhullar M, Macrae F, Brown G, Smith M, Sharpe K. Prediction of Crohn’s disease aggression through NOD2/CARD15 gene sequencing in an Australian cohort. World J Gastroenterol 2014; 20(17): 5008-5016 [PMID: 24803813 DOI: 10.3748/wjg.v20.i17.5008] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
299 Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777-782. [PMID: 11709511 DOI: 10.1136/gut.49.6.777,] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
300 Harel E, Rubinstein A, Nissan A, Khazanov E, Nadler Milbauer M, Barenholz Y, Tirosh B. Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa. PLoS One 2011;6:e24202. [PMID: 21915296 DOI: 10.1371/journal.pone.0024202] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
301 Caviglia R, Boskoski I, Cicala M. Maintenance treatment with infliximab for the management of Crohn's disease in adults. Biologics 2009;3:39-49. [PMID: 19707394 DOI: 10.2147/btt.2009.2763] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
302 Sato K, Shiota M, Fukuda S, Iwamoto E, Machida H, Inamine T, Kondo S, Yanagihara K, Isomoto H, Mizuta Y, Kohno S, Tsukamoto K. Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based biomarker for susceptibility to Crohn's disease in the Japanese population. J Clin Immunol. 2009;29:815-825. [PMID: 19653082 DOI: 10.1007/s10875-009-9320-x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
303 Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol. 2002;160:739-751. [PMID: 11839595 DOI: 10.1016/s0002-9440(10)64894-8] [Cited by in Crossref: 101] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
304 Vemu B, Selvasubramanian S, Pandiyan V. Emu oil offers protection in Crohn's disease model in rats. BMC Complement Altern Med 2016;16:55. [PMID: 26852336 DOI: 10.1186/s12906-016-1035-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
305 Katsinelos P, Kountouras J, Paroutoglou G, Zavos C. Alopecia areata, primary sclerosing cholangitis, and ulcerative colitis: autoimmunity and apoptosis as common links? Dig Dis Sci. 2007;52:1288-1292. [PMID: 17372831 DOI: 10.1007/s10620-006-9265-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
306 Li C, Zhou HM. The role of manganese superoxide dismutase in inflammation defense. Enzyme Res 2011;2011:387176. [PMID: 21977313 DOI: 10.4061/2011/387176] [Cited by in Crossref: 39] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
307 Chin AC, Teoh DA, Scott KG, Meddings JB, Macnaughton WK, Buret AG. Strain-dependent induction of enterocyte apoptosis by Giardia lamblia disrupts epithelial barrier function in a caspase-3-dependent manner. Infect Immun 2002;70:3673-80. [PMID: 12065509 DOI: 10.1128/IAI.70.7.3673-3680.2002] [Cited by in Crossref: 155] [Cited by in F6Publishing: 77] [Article Influence: 7.8] [Reference Citation Analysis]
308 Nelson HA, Roe MW. Molecular physiology and pathophysiology of stromal interaction molecules. Exp Biol Med (Maywood) 2018;243:451-72. [PMID: 29363328 DOI: 10.1177/1535370218754524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
309 Kanai T, Ilyama R, Ishikura T, Uraushihara K, Totsuka T, Yamazaki M, Nakamuma T, Watanabe M. Role of the innate immune system in the development of chronic colitis. J Gastroenterol 2002;37 Suppl 14:38-42. [PMID: 12572864 DOI: 10.1007/BF03326411] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
310 Biancone L, Orlando A, Kohn A, Colombo E, Sostegni R, Angelucci E, Rizzello F, Castiglione F, Benazzato L, Papi C, Meucci G, Riegler G, Petruzziello C, Mocciaro F, Geremia A, Calabrese E, Cottone M, Pallone F. Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. Gut 2006;55:228-33. [PMID: 16120759 DOI: 10.1136/gut.2005.075937] [Cited by in Crossref: 96] [Cited by in F6Publishing: 77] [Article Influence: 5.6] [Reference Citation Analysis]
311 Torres M, Ríos A. Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. World J Gastroenterol 2008; 14(13): 1972-1980 [PMID: 18395894 DOI: 10.3748/wjg.14.1972] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 60] [Article Influence: 4.4] [Reference Citation Analysis]
312 Yu FY, Huang SG, Zhang HY, Ye H, Chi HG, Zou Y, Lv RX, Zheng XB. Effects of baicalin in CD4 + CD29 + T cell subsets of ulcerative colitis patients. World J Gastroenterol 2014; 20(41): 15299-15309 [PMID: 25386078 DOI: 10.3748/wjg.v20.i41.15299] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
313 Mendoza JL, Urcelay E, Lana R, Martinez A, Taxonera C, Concha EGL, Díaz-Rubio M. Polymorphisms in interleukin-10 gene according to mutations of NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn’s disease. World J Gastroenterol 2006; 12(3): 443-448 [PMID: 16489646 DOI: 10.3748/wjg.v12.i3.443] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
314 Wiercinska-Drapalo A, Flisiak R, Jaroszewicz J, Prokopowicz D. Plasma interleukin-18 reflects severity of ulcerative colitis. World J Gastroenterol 2005; 11(4): 605-608 [PMID: 15641156 DOI: 10.3748/wjg.v11.i4.605] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
315 Courreges MC, Kantake N, Goetz DJ, Schwartz FL, McCall KD. Phenylmethimazole blocks dsRNA-induced IRF3 nuclear translocation and homodimerization. Molecules 2012;17:12365-77. [PMID: 23090018 DOI: 10.3390/molecules171012365] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
316 Pavlidis S, Monast C, Loza MJ, Branigan P, Chung KF, Adcock IM, Guo Y, Rowe A, Baribaud F. I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment. PLoS Comput Biol 2019;15:e1006951. [PMID: 31039157 DOI: 10.1371/journal.pcbi.1006951] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
317 Lomax AE, Mawe GM, Sharkey KA. Synaptic facilitation and enhanced neuronal excitability in the submucosal plexus during experimental colitis in guinea-pig. J Physiol. 2005;564:863-875. [PMID: 15774518 DOI: 10.1113/jphysiol.2005.084285] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 4.2] [Reference Citation Analysis]
318 Pan L, Farouk MH, Qin G, Zhao Y, Bao N. The Influences of Soybean Agglutinin and Functional Oligosaccharides on the Intestinal Tract of Monogastric Animals. Int J Mol Sci 2018;19:E554. [PMID: 29439523 DOI: 10.3390/ijms19020554] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
319 Xu W, Ou W, Guo Y, Gu Y, Cui L, Zhong J, Du P. Clinical outcomes and risk factors of secondary extraintestinal manifestation in ulcerative colitis: results of a multicenter and long-term follow-up retrospective study. PeerJ 2019;7:e7194. [PMID: 31304061 DOI: 10.7717/peerj.7194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
320 Miklavcic JJ, Li Q, Skolnick J, Thomson ABR, Mazurak VC, Clandinin MT. Ganglioside Alters Phospholipase Trafficking, Inhibits NF-κB Assembly, and Protects Tight Junction Integrity. Front Nutr 2021;8:705172. [PMID: 34291075 DOI: 10.3389/fnut.2021.705172] [Reference Citation Analysis]
321 Ruemmele FM, Beaulieu JF, Dionne S, Levy E, Seidman EG, Cerf-Bensussan N, Lentze MJ. Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha. Gut 2002;51:842-8. [PMID: 12427787 DOI: 10.1136/gut.51.6.842] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 3.7] [Reference Citation Analysis]
322 Mărginean CO, Meliţ LE, Mocanu S, Mărginean MO. Inflammatory bowel diseases: a burden in pediatrics: Case series and a review of the literature. Medicine (Baltimore) 2017;96:e6329. [PMID: 28296755 DOI: 10.1097/MD.0000000000006329] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
323 Singh UP, Singh NP, Singh B, Hofseth LJ, Price RL, Nagarkatti M, Nagarkatti PS. Resveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis. J Pharmacol Exp Ther. 2010;332:829-839. [PMID: 19940103 DOI: 10.1124/jpet.109.160838] [Cited by in Crossref: 120] [Cited by in F6Publishing: 125] [Article Influence: 9.2] [Reference Citation Analysis]
324 Fiorucci S, Mencarelli A, Palazzetti B, Distrutti E, Vergnolle N, Hollenberg MD, Wallace JL, Morelli A, Cirino G. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci USA. 2001;98:13936-13941. [PMID: 11717450 DOI: 10.1073/pnas.241377298] [Cited by in Crossref: 145] [Cited by in F6Publishing: 132] [Article Influence: 7.3] [Reference Citation Analysis]
325 Yao J, Wei C, Wang JY, Zhang R, Li YX, Wang LS. Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice. World J Gastroenterol 2015; 21(21): 6572-6581 [PMID: 26074695 DOI: 10.3748/wjg.v21.i21.6572] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
326 Minaiyan M, Ghassemi-Dehkordi N, Mahzouni P, Ahmadi NS. Anti-inflammatory effect of Helichrysum oligocephalum DC extract on acetic acid - Induced acute colitis in rats. Adv Biomed Res. 2014;3:87. [PMID: 24761395 DOI: 10.4103/2277-9175.128000] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
327 Veluswamy H, Suryawala K, Sheth A, Wells S, Salvatierra E, Cromer W, Chaitanya GV, Painter A, Patel M, Manas K. African-American inflammatory bowel disease in a Southern U.S. health center. BMC Gastroenterol. 2010;10:104. [PMID: 20828408 DOI: 10.1186/1471-230x-10-104] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
328 Katsurada T, Kobayashi W, Tomaru U, Baba T, Furukawa S, Ishizu A, Takeda K, Sakamoto N, Asaka M, Takeda H, Kasahara M. Decrease of peripheral and intestinal NKG2A-positive T cells in patients with ulcerative colitis. PLoS One 2012;7:e44113. [PMID: 22970169 DOI: 10.1371/journal.pone.0044113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
329 Bozec D, Iuga AC, Roda G, Dahan S, Yeretssian G. Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis. Oncotarget. 2016;7:46384-46400. [PMID: 27344176 DOI: 10.18632/oncotarget.10135] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
330 Gu P, Theiss A, Han J, Feagins LA. Increased Cell Adhesion Molecules, PECAM-1, ICAM-3, or VCAM-1, Predict Increased Risk for Flare in Patients With Quiescent Inflammatory Bowel Disease. J Clin Gastroenterol 2017;51:522-7. [PMID: 27552332 DOI: 10.1097/MCG.0000000000000618] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
331 Kim HJ, Li H, Collins JJ, Ingber DE. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci USA. 2016;113:E7-15. [PMID: 26668389 DOI: 10.1073/pnas.1522193112] [Cited by in Crossref: 435] [Cited by in F6Publishing: 408] [Article Influence: 62.1] [Reference Citation Analysis]
332 Jergens AE, Wilson-Welder JH, Dorn A, Henderson A, Liu Z, Evans RB, Hostetter J, Wannemuehler MJ. Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut 2007;56:934-40. [PMID: 17145736 DOI: 10.1136/gut.2006.099242] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 4.6] [Reference Citation Analysis]
333 Engel T, Kopylov U. Ustekinumab in Crohn’s disease: evidence to date and place in therapy. Ther Adv Chronic Dis. 2016;7:208-214. [PMID: 27433311 DOI: 10.1177/2040622316653306] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
334 Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, Johnson IT, Narbad A. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010;10:134. [PMID: 21073731 DOI: 10.1186/1471-230x-10-134] [Cited by in Crossref: 145] [Cited by in F6Publishing: 75] [Article Influence: 12.1] [Reference Citation Analysis]
335 Fiocchi C. TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation. J Clin Invest. 2001;108:523-526. [PMID: 11518725 DOI: 10.1172/jci13863] [Cited by in Crossref: 53] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
336 Finnberg NK, Liu Y, El-Deiry WS. Detection of DSS-induced gastrointestinal mucositis in mice by non-invasive optical near-infrared (NIR) imaging of cathepsin activity. Cancer Biol Ther. 2013;14:736-741. [PMID: 23792573 DOI: 10.4161/cbt.25094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
337 Alt C, Lam JS, Harrison MT, Kershaw KM, Samuelsson S, Toll L, D'Andrea A. Nociceptin/orphanin FQ inhibition with SB612111 ameliorates dextran sodium sulfate-induced colitis. Eur J Pharmacol 2012;683:285-93. [PMID: 22449384 DOI: 10.1016/j.ejphar.2012.03.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
338 Wen XD, Wang CZ, Yu C, Zhao L, Zhang Z, Matin A, Wang Y, Li P, Xiao SY, Du W, He TC, Yuan CS. Panax notoginseng attenuates experimental colitis in the azoxymethane/dextran sulfate sodium mouse model. Phytother Res. 2014;28:892-898. [PMID: 24142591 DOI: 10.1002/ptr.5066] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
339 Nishiyama Y, Kataoka T, Yamato K, Taguchi T, Yamaoka K. Suppression of dextran sulfate sodium-induced colitis in mice by radon inhalation. Mediators Inflamm 2012;2012:239617. [PMID: 23365486 DOI: 10.1155/2012/239617] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
340 Jenkins HR. Inflammatory bowel disease. Arch Dis Child 2001;85:435-7. [PMID: 11668114 DOI: 10.1136/adc.85.5.435] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
341 Zhang R, Gilbert S, Yao X, Vallance J, Steinbrecher K, Moriggl R, Zhang D, Eluri M, Chen H, Cao H, Shroyer N, Denson L, Han X. Natural compound methyl protodioscin protects against intestinal inflammation through modulation of intestinal immune responses. Pharmacol Res Perspect 2015;3:e00118. [PMID: 26038694 DOI: 10.1002/prp2.118] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
342 Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut. 2002;51:405-409. [PMID: 12171964 DOI: 10.1136/gut.51.3.405] [Cited by in Crossref: 375] [Cited by in F6Publishing: 315] [Article Influence: 18.8] [Reference Citation Analysis]
343 Wong L, Hutson PR, Bushman W. Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection. PLoS One 2014;9:e100770. [PMID: 24950301 DOI: 10.1371/journal.pone.0100770] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
344 Uzoigwe JC, Khaitsa ML, Gibbs PS. Epidemiological evidence for Mycobacterium avium subspecies paratuberculosis as a cause of Crohn's disease. Epidemiol Infect 2007;135:1057-68. [PMID: 17445316 DOI: 10.1017/S0950268807008448] [Cited by in Crossref: 63] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
345 Wagoner ST, Kavookjian J. The Influence of Motivational Interviewing on Patients With Inflammatory Bowel Disease: A Systematic Review of the Literature. J Clin Med Res 2017;9:659-66. [PMID: 28725313 DOI: 10.14740/jocmr3081w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
346 Song JL, Choi JH, Seo JH, Lim YI, Park KY. Anti-colitic effects of kanjangs (fermented soy sauce and sesame sauce) in dextran sulfate sodium-induced colitis in mice. J Med Food 2014;17:1027-35. [PMID: 25188463 DOI: 10.1089/jmf.2013.3119] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
347 Choi SY, Hur SJ, An CS, Jeon YH, Jeoung YJ, Bak JP, Lim BO. Anti-inflammatory effects of Inonotus obliquus in colitis induced by dextran sodium sulfate. J Biomed Biotechnol 2010;2010:943516. [PMID: 20300439 DOI: 10.1155/2010/943516] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
348 Fiorucci S, Wallace JL, Mencarelli A, Distrutti E, Rizzo G, Farneti S, Morelli A, Tseng JL, Suramanyam B, Guilford WJ. A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc Natl Acad Sci USA. 2004;101:15736-15741. [PMID: 15505205 DOI: 10.1073/pnas.0404722101] [Cited by in Crossref: 118] [Cited by in F6Publishing: 110] [Article Influence: 6.6] [Reference Citation Analysis]
349 Takagi T, Naito Y, Uchiyama K, Okuda T, Mizushima K, Suzuki T, Handa O, Ishikawa T, Yagi N, Kokura S, Ichikawa H, Yoshikawa T. Rebamipide promotes healing of colonic ulceration through enhanced epithelial restitution. World J Gastroenterol 2011; 17(33): 3802-3809 [PMID: 21987622 DOI: 10.3748/wjg.v17.i33.3802] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
350 Kugathasan S, Saubermann LJ, Smith L, Kou D, Itoh J, Binion DG, Levine AD, Blumberg RS, Fiocchi C. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut. 2007;56:1696-1705. [PMID: 17682002 DOI: 10.1136/gut.2006.116467] [Cited by in Crossref: 126] [Cited by in F6Publishing: 125] [Article Influence: 8.4] [Reference Citation Analysis]
351 Principi M, Giorgio F, Losurdo G, Neve V, Contaldo A, Di Leo A, Ierardi E. Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? World J Gastrointest Pathophysiol 2013; 4(4): 100-107 [PMID: 24244878 DOI: 10.4291/wjgp.v4.i4.100] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
352 McNamee EN, Wermers JD, Masterson JC, Collins CB, Lebsack MD, Fillon S, Robinson ZD, Grenawalt J, Lee JJ, Jedlicka P, Furuta GT, Rivera-Nieves J. Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse. Inflamm Bowel Dis 2010;16:743-52. [PMID: 19856411 DOI: 10.1002/ibd.21148] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
353 Lanas A. Role of nitric oxide in the gastrointestinal tract. Arthritis Res Ther 2008;10 Suppl 2:S4. [PMID: 19007429 DOI: 10.1186/ar2465] [Cited by in Crossref: 98] [Cited by in F6Publishing: 84] [Article Influence: 7.0] [Reference Citation Analysis]
354 Malekinejad H, Shafie-Irannejad V, Hobbenaghi R, Tabatabaie SH, Moshtaghion SM. Comparative protective effect of hawthorn berry hydroalcoholic extract, atorvastatin, and mesalamine on experimentally induced colitis in rats. J Med Food 2013;16:593-601. [PMID: 23875899 DOI: 10.1089/jmf.2012.2672] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
355 Holland N, Dong J, Garnett E, Shaikh N, Huen K, Harmatz P, Olive A, Winter HS, Gold BD, Cohen SA, Baldassano RN, Kirschner BS, Heyman MB. Reduced intracellular T-helper 1 interferon-gamma in blood of newly diagnosed children with Crohn's disease and age-related changes in Th1/Th2 cytokine profiles. Pediatr Res 2008;63:257-62. [PMID: 18287963 DOI: 10.1203/PDR.0b013e318163a897] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
356 Bekheit M, Baddour N, Katri K, Taher Y, El Tobgy K, Mousa E. Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series. BMJ Open Gastroenterol. 2016;3:e000082. [PMID: 27195128 DOI: 10.1136/bmjgast-2016-000082] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
357 Samanta AK, Torok VA, Percy NJ, Abimosleh SM, Howarth GS. Microbial fingerprinting detects unique bacterial communities in the faecal microbiota of rats with experimentally-induced colitis. J Microbiol. 2012;50:218-225. [PMID: 22538649 DOI: 10.1007/s12275-012-1362-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
358 Treede I, Braun A, Jeliaskova P, Giese T, Füllekrug J, Griffiths G, Stremmel W, Ehehalt R. TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells. BMC Gastroenterol 2009;9:53. [PMID: 19594939 DOI: 10.1186/1471-230X-9-53] [Cited by in Crossref: 60] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
359 Neunlist M, Aubert P, Toquet C, Oreshkova T, Barouk J, Lehur PA, Schemann M, Galmiche JP. Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut. 2003;52:84-90. [PMID: 12477766 DOI: 10.1136/gut.52.1.84] [Cited by in Crossref: 122] [Cited by in F6Publishing: 126] [Article Influence: 6.4] [Reference Citation Analysis]
360 Tilg H, Vogelsang H, Ludwiczek O, Lochs H, Kaser A, Colombel JF, Ulmer H, Rutgeerts P, Krüger S, Cortot A, D'Haens G, Harrer M, Gasche C, Wrba F, Kuhn I, Reinisch W. A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut 2003;52:1728-33. [PMID: 14633951 DOI: 10.1136/gut.52.12.1728] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 3.4] [Reference Citation Analysis]
361 Souza HS, Tortori CJ, Castelo-Branco MT, Carvalho AT, Margallo VS, Delgado CF, Dines I, Elia CC. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways. Int J Colorectal Dis. 2005;20:277-286. [PMID: 15503066 DOI: 10.1007/s00384-004-0639-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 3.4] [Reference Citation Analysis]
362 Huang YT, Wen CC, Chen YH, Huang WC, Huang LT, Lin WC, Arulselvan P, Liao JW, Lin SH, Hsiao PW, Kuo SC, Yang NS. Dietary uptake of Wedelia chinensis extract attenuates dextran sulfate sodium-induced colitis in mice. PLoS One 2013;8:e64152. [PMID: 23734189 DOI: 10.1371/journal.pone.0064152] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
363 Ogawa C, Liu YJ, Kobayashi KS. Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd 2011;7:180-97. [PMID: 22180736 DOI: 10.2174/157340711796817913] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
364 Vetuschi A, Latella G, Sferra R, Caprilli R, Gaudio E. Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci. 2002;47:1447-1457. [PMID: 12141799 DOI: 10.1023/a:1015931128583] [Cited by in Crossref: 85] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
365 Jarry A, Bossard C, Bou-Hanna C, Masson D, Espaze E, Denis MG, Laboisse CL. Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants. J Clin Invest. 2008;118:1132-1142. [PMID: 18259614 DOI: 10.1172/jci32140] [Cited by in Crossref: 22] [Cited by in F6Publishing: 59] [Article Influence: 1.6] [Reference Citation Analysis]
366 Sitohy B, Hammarström S, Danielsson A, Hammarström ML. Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. Clin Exp Immunol 2008;151:326-33. [PMID: 18190460 DOI: 10.1111/j.1365-2249.2007.03566.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
367 Nahidi L, Day AS, Lemberg DA, Leach ST. Paediatric inflammatory bowel disease: a mechanistic approach to investigate exclusive enteral nutrition treatment. Scientifica (Cairo) 2014;2014:423817. [PMID: 24967146 DOI: 10.1155/2014/423817] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
368 Lu Y, Lin H, Zhang J, Wei J, Sun J, Han L. Sijunzi Decoction attenuates 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats and ameliorates TNBS-induced claudin-2 damage via NF-κB pathway in Caco2 cells. BMC Complement Altern Med 2017;17:35. [PMID: 28073341 DOI: 10.1186/s12906-016-1549-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
369 Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV; Mucositis Study Group of Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Emerging evidence on the pathobiology of mucositis. Support Care Cancer 2013;21:2075-83. [PMID: 23604521 DOI: 10.1007/s00520-013-1810-y] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis]
370 Gasche C, Bakos S, Dejaco C, Tillinger W, Zakeri S, Reinisch W. IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease. J Clin Immunol. 2000;20:362-370. [PMID: 11051278 DOI: 10.1023/a:1006672114184] [Cited by in Crossref: 51] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
371 Goggins MG, Goh J, O’Connell MA, Weir DG, Kelleher D, Mahmud N. Soluble adhesion molecules in inflammatory bowel disease. Ir J Med Sci. 2001;170:107-111. [PMID: 11491044 DOI: 10.1007/bf03168821] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
372 de Vallière C, Bäbler K, Busenhart P, Schwarzfischer M, Maeyashiki C, Schuler C, Atrott K, Lang S, Spalinger MR, Scharl M, Ruiz-Castro PA, Hausmann M, Rogler G. A Novel OGR1 (GPR68) Inhibitor Attenuates Inflammation in Murine Models of Colitis. Inflamm Intest Dis 2021;6:140-53. [PMID: 34722644 DOI: 10.1159/000517474] [Reference Citation Analysis]
373 Stallmach A, Marth T, Weiss B, Wittig BM, Hombach A, Schmidt C, Neurath M, Zeitz M, Zeuzem S, Abken H. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo. Gut 2004;53:339-45. [PMID: 14960512 DOI: 10.1136/gut.2003.020107] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
374 Menozzi A, Dall'Aglio M, Quintavalla F, Dallavalle L, Meucci V, Bertini S. Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial. BMC Vet Res 2016;12:217. [PMID: 27716258 DOI: 10.1186/s12917-016-0851-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
375 Cho J, Kweon HS, Huh SO, Sadra A. Augmented reduction in colonic inflammatory markers of dextran sulfate sodium-induced colitis with a combination of 5-aminosalicylic acid and AD-lico™ from Glycyrrhiza inflata. Anim Cells Syst (Seoul) 2018;22:189-96. [PMID: 30460097 DOI: 10.1080/19768354.2018.1476409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
376 Thornton NL, Cody MJ, Yost CC. Toll-like receptor 1/2 stimulation induces elevated interleukin-8 secretion in polymorphonuclear leukocytes isolated from preterm and term newborn infants. Neonatology 2012;101:140-6. [PMID: 21952587 DOI: 10.1159/000330567] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
377 Zhang DK, Yu JJ, Li YM, Wei LN, Yu Y, Feng YH, Wang X. A Picrorhiza kurroa derivative, picroliv, attenuates the development of dextran-sulfate-sodium-induced colitis in mice. Mediators Inflamm. 2012;2012:751629. [PMID: 23125487 DOI: 10.1155/2012/751629] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
378 Singh UP, Singh NP, Murphy EA, Price RL, Fayad R, Nagarkatti M, Nagarkatti PS. Chemokine and cytokine levels in inflammatory bowel disease patients. Cytokine. 2016;77:44-49. [PMID: 26520877 DOI: 10.1016/j.cyto.2015.10.008] [Cited by in Crossref: 111] [Cited by in F6Publishing: 110] [Article Influence: 15.9] [Reference Citation Analysis]
379 Casellas F, López-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res. 2002;11:775-781. [PMID: 12482161 DOI: 10.1023/a:1020841601110] [Cited by in Crossref: 129] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
380 Kondreddy V, Keshava S, Esmon CT, Pendurthi UR, Rao LVM. A critical role of endothelial cell protein C receptor in the intestinal homeostasis in experimental colitis. Sci Rep 2020;10:20569. [PMID: 33239717 DOI: 10.1038/s41598-020-77502-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
381 Morshedzadeh N, Rahimlou M, Asadzadeh Aghdaei H, Shahrokh S, Reza Zali M, Mirmiran P. Association Between Adipokines Levels with Inflammatory Bowel Disease (IBD): Systematic Reviews. Dig Dis Sci 2017;62:3280-6. [PMID: 29086333 DOI: 10.1007/s10620-017-4806-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
382 Shen Z, Feng Y, Rogers AB, Rickman B, Whary MT, Xu S, Clapp KM, Boutin SR, Fox JG. Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice. Infect Immun 2009;77:2508-16. [PMID: 19307212 DOI: 10.1128/IAI.00166-09] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
383 Utech M, Mennigen R, Bruewer M. Endocytosis and recycling of tight junction proteins in inflammation. J Biomed Biotechnol 2010;2010:484987. [PMID: 20011071 DOI: 10.1155/2010/484987] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
384 Jian YT, Mai GF, Wang JD, Zhang YL, Luo RC, Fang YX. Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol 2005; 11(12): 1747-1752 [PMID: 15793857 DOI: 10.3748/wjg.v11.i12.1747] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 77] [Article Influence: 4.9] [Reference Citation Analysis]
385 Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol 2008; 14(3): 348-353 [PMID: 18200658 DOI: 10.3748/wjg.14.348] [Cited by in CrossRef: 211] [Cited by in F6Publishing: 208] [Article Influence: 15.1] [Reference Citation Analysis]
386 Lleal M, Sarrabayrouse G, Willamil J, Santiago A, Pozuelo M, Manichanh C. A single faecal microbiota transplantation modulates the microbiome and improves clinical manifestations in a rat model of colitis. EBioMedicine 2019;48:630-41. [PMID: 31628021 DOI: 10.1016/j.ebiom.2019.10.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
387 Hanai H, Watanabe F, Saniabadi AR, Matsushitai I, Takeuchi K, Iida T. Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci. 2002;47:2349-2353. [PMID: 12395908 DOI: 10.1023/a:1020159932758] [Cited by in Crossref: 69] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
388 Arab HH, Al-Shorbagy MY, Abdallah DM, Nassar NN. Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease. PLoS One. 2014;9:e97193. [PMID: 24831514 DOI: 10.1371/journal.pone.0097193] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
389 Mahendran V, Riordan SM, Grimm MC, Tran TA, Major J, Kaakoush NO, Mitchell H, Zhang L. Prevalence of Campylobacter species in adult Crohn’s disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS One. 2011;6:e25417. [PMID: 21966525 DOI: 10.1371/journal.pone.0025417] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 7.5] [Reference Citation Analysis]
390 Paramsothy S, Rosenstein AK, Mehandru S, Colombel JF. The current state of the art for biological therapies and new small molecules in inflammatory bowel disease. Mucosal Immunol 2018;11:1558-70. [PMID: 29907872 DOI: 10.1038/s41385-018-0050-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]
391 Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005;28:187-196. [PMID: 16129903 DOI: 10.1385/criai: 28: 3: 187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
392 Alkim C, Alkim H, Koksal AR, Boga S, Sen I. Angiogenesis in Inflammatory Bowel Disease. Int J Inflam 2015;2015:970890. [PMID: 26839731 DOI: 10.1155/2015/970890] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
393 Fichtner-Feigl S, Strober W, Geissler EK, Schlitt HJ. Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis. Mucosal Immunol. 2008;1 Suppl 1:S24-S27. [PMID: 19079223 DOI: 10.1038/mi.2008.41] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
394 Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777-782. [PMID: 11709511 DOI: 10.1136/gut.49.6.777] [Cited by in Crossref: 636] [Cited by in F6Publishing: 577] [Article Influence: 30.3] [Reference Citation Analysis]
395 Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL, Olivares M, Xaus J, Zarzuelo A, Galvez J. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int J Colorectal Dis. 2006;21:737-746. [PMID: 16052308 DOI: 10.1007/s00384-005-0773-y] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 4.8] [Reference Citation Analysis]
396 Danese S, Sans M, Fiocchi C. The CD40/CD40L costimulatory pathway in inflammatory bowel disease. Gut. 2004;53:1035-1043. [PMID: 15194658 DOI: 10.1136/gut.2003.026278] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 4.6] [Reference Citation Analysis]
397 Wan J, Xia L, Xu W, Lu N. Expression and Function of miR-155 in Diseases of the Gastrointestinal Tract.Int J Mol Sci. 2016;17. [PMID: 27187359 DOI: 10.3390/ijms17050709] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
398 Li YZ, Sun KX, Zhao C. Expression of Foxp3 mRNA in peripheral blood monocytes of patients with ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2006; 14(8): 810-813 [DOI: 10.11569/wcjd.v14.i8.810] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
399 Hussein IAH, Tohme R, Barada K, Mostafa MH, Freund JN, Jurjus RA, Karam W, Jurjus A. Inflammatory bowel disease in rats: Bacterial and chemical interaction. World J Gastroenterol 2008; 14(25): 4028-4039 [PMID: 18609687 DOI: 10.3748/wjg.14.4028] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
400 Seril DN, Liao J, Ho KL, Warsi A, Yang CS, Yang GY. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci. 2002;47:1266-1278. [PMID: 12064801 DOI: 10.1023/a:1015362228659] [Cited by in Crossref: 112] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
401 Barton SG, Rampton DS, Winrow VR, Domizio P, Feakins RM. Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones. 2003;8:329-334. [PMID: 15115285 DOI: 10.1379/1466-1268(2003)008<0329: eohsph>2.0.co; 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
402 Parekh AB. Store-operated CRAC channels: function in health and disease. Nat Rev Drug Discov 2010;9:399-410. [PMID: 20395953 DOI: 10.1038/nrd3136] [Cited by in Crossref: 223] [Cited by in F6Publishing: 214] [Article Influence: 18.6] [Reference Citation Analysis]
403 Nie Y, Lin Q, Luo F. Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease. Int J Mol Sci. 2017;18:pii: E1372. [PMID: 28654020 DOI: 10.3390/ijms18071372] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 10.8] [Reference Citation Analysis]
404 Melgar S, Yeung MM, Bas A, Forsberg G, Suhr O, Oberg A, Hammarstrom S, Danielsson A, Hammarstrom ML. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol. 2003;134:127-137. [PMID: 12974765 DOI: 10.1046/j.1365-2249.2003.02268.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 104] [Article Influence: 5.4] [Reference Citation Analysis]
405 Voudoukis E, Karmiris K, Koutroubakis IE. Multipotent role of platelets in inflammatory bowel diseases: A clinical approach. World J Gastroenterol 2014; 20(12): 3180-3190 [PMID: 24696603 DOI: 10.3748/wjg.v20.i12.3180] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
406 Mosli M, Bamarhul M, Alharbi A, Shafei S, Alharbi A, Bamahfouth K, Jawa H, Aljahdali E, Bazaraa S, Qari Y. Screening irritable bowel syndrome patients for symptoms predictive of crohn's disease using the red flag score. Saudi J Gastroenterol 2017;23:229-32. [PMID: 28721976 DOI: 10.4103/sjg.SJG_601_16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
407 Fiorucci S, Antonelli E, Distrutti E, Del Soldato P, Flower RJ, Clark MJ, Morelli A, Perretti M, Ignarro LJ. NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Proc Natl Acad Sci USA. 2002;99:15770-15775. [PMID: 12427966 DOI: 10.1073/pnas.232583599] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 3.1] [Reference Citation Analysis]
408 Franzin M, Stefančič K, Lucafò M, Decorti G, Stocco G. Microbiota and Drug Response in Inflammatory Bowel Disease. Pathogens 2021;10:211. [PMID: 33669168 DOI: 10.3390/pathogens10020211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
409 Bao X, Feng Z, Yao J, Li T, Yin Y. Roles of Dietary Amino Acids and Their Metabolites in Pathogenesis of Inflammatory Bowel Disease. Mediators Inflamm. 2017;2017:6869259. [PMID: 28392631 DOI: 10.1155/2017/6869259] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
410 Jang YJ, Kim WK, Han DH, Lee K, Ko G. Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota. Gut Microbes 2019;10:696-711. [PMID: 30939976 DOI: 10.1080/19490976.2019.1589281] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 13.7] [Reference Citation Analysis]
411 Nunes T, Fiorino G, Danese S, Sans M. Familial aggregation in inflammatory bowel disease: Is it genes or environment? World J Gastroenterol 2011; 17(22): 2715-2722 [PMID: 21734779 DOI: 10.3748/wjg.v17.i22.2715] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
412 Datta De D, Bhattacharjya S, Maitra M, Datta A, Choudhury A, Dhali GK, Roychoudhury S. IL1B induced Smad 7 negatively regulates gastrin expression. PLoS One. 2011;6:e14775. [PMID: 21445336 DOI: 10.1371/journal.pone.0014775] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
413 Pallone F, Blanco Gdel V, Vavassori P, Monteleone I, Fina D, Monteleone G. Genetic and pathogenetic insights into inflammatory bowel disease. Curr Gastroenterol Rep. 2003;5:487-492. [PMID: 14602058 DOI: 10.1007/s11894-003-0038-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
414 De Simone M, Ciulla MM, Cioffi U, Poggi L, Oreggia B, Paliotti R, Botti F, Carrara A, Agosti F, Sartorio A, Contessini-Avesani E. Effects of surgery on peripheral N-terminal propeptide of type III procollagen in patients with Crohn's disease. J Gastrointest Surg 2007;11:1361-4. [PMID: 17687618 DOI: 10.1007/s11605-007-0233-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
415 Garg P, Sarma D, Jeppsson S, Patel NR, Gewirtz AT, Merlin D, Sitaraman SV. Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer. Cancer Res 2010;70:792-801. [PMID: 20068187 DOI: 10.1158/0008-5472.CAN-09-3166] [Cited by in Crossref: 59] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
416 Lesage S, Zouali H, Cézard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP; EPWG-IBD Group., EPIMAD Group., GETAID Group. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57. [PMID: 11875755 DOI: 10.1086/339432] [Cited by in Crossref: 652] [Cited by in F6Publishing: 644] [Article Influence: 32.6] [Reference Citation Analysis]
417 Wei C, Wang JY, Xiong F, Wu BH, Luo MH, Yu ZC, Liu TT, Li DF, Tang Q, Li YX, Zhang DG, Xu ZL, Jin HT, Wang LS, Yao J. Curcumin ameliorates DSS‑induced colitis in mice by regulating the Treg/Th17 signaling pathway. Mol Med Rep 2021;23:34. [PMID: 33179078 DOI: 10.3892/mmr.2020.11672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
418 Oron T, Elad-Sfadia G, Haklai R, Aizman E, Brazowski E, Kloog Y, Reif S. Prevention of induced colitis in mice by the ras antagonist farnesylthiosalicylic acid. Dig Dis Sci 2012;57:320-6. [PMID: 21901261 DOI: 10.1007/s10620-011-1880-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
419 Ni Y, Liu M, Yu H, Chen Y, Liu Y, Chen S, Ruan J, Da A, Zhang Y, Wang T. Desmethylbellidifolin From Gentianella acuta Ameliorate TNBS-Induced Ulcerative Colitis Through Antispasmodic Effect and Anti-Inflammation. Front Pharmacol 2019;10:1104. [PMID: 31616306 DOI: 10.3389/fphar.2019.01104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
420 Xu J, Zhou L, Ji L, Chen F, Fortmann K, Zhang K, Liu Q, Li K, Wang W, Wang H, Xie W, Wang Q, Liu J, Zheng B, Zhang P, Huang S, Shi T, Zhang B, Dang Y, Chen J, O'Malley BW, Moses RE, Wang P, Li L, Xiao J, Hoffmann A, Li X. The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitis. Nat Commun 2016;7:10761. [PMID: 26899380 DOI: 10.1038/ncomms10761] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
421 Carty E, Rampton DS. Evaluation of new therapies for inflammatory bowel disease. Br J Clin Pharmacol 2003;56:351-61. [PMID: 12968979 DOI: 10.1046/j.1365-2125.2003.01965.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
422 Bridger S, Lee JC, Bjarnason I, Jones JE, Macpherson AJ. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Gut. 2002;51:21-25. [PMID: 12077086 DOI: 10.1136/gut.51.1.21] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 4.8] [Reference Citation Analysis]
423 Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, Prokopowicz D. Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 as biomarkers of ulcerative colitis activity. World J Gastroenterol 2003; 9(12): 2843-2845 [PMID: 14669348 DOI: 10.3748/wjg.v9.i12.2843] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
424 Künzli BM, Berberat PO, Dwyer K, Deaglio S, Csizmadia E, Cowan P, d'Apice A, Moore G, Enjyoji K, Friess H, Robson SC. Variable impact of CD39 in experimental murine colitis. Dig Dis Sci 2011;56:1393-403. [PMID: 20936356 DOI: 10.1007/s10620-010-1425-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
425 Stallmach A, Giese T, Schmidt C, Ludwig B, Mueller-molaian I, Meuer SC. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn?s disease. International Journal of Colorectal Disease 2004;19:308-15. [DOI: 10.1007/s00384-003-0554-4] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 4.4] [Reference Citation Analysis]
426 Yanaba K, Asano Y, Tada Y, Sugaya M, Kadono T, Sato S. Proteasome inhibitor bortezomib ameliorates intestinal injury in mice. PLoS One. 2012;7:e34587. [PMID: 22479648 DOI: 10.1371/journal.pone.0034587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
427 Cantarelli BCF, de Oliveira RS, Alves AMA, Ribeiro BJ, Velloni F, D'Ippolito G. Evaluating inflammatory activity in Crohn's disease by cross-sectional imaging techniques. Radiol Bras 2020;53:38-46. [PMID: 32313336 DOI: 10.1590/0100-3984.2018.0096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
428 Rossignol DA. Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis. Med Gas Res. 2012;2:6. [PMID: 22417628 DOI: 10.1186/2045-9912-2-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
429 Marini M, Bamias G, Rivera-Nieves J, Moskaluk CA, Hoang SB, Ross WG, Pizarro TT, Cominelli F. TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc Natl Acad Sci USA. 2003;100:8366-8371. [PMID: 12832622 DOI: 10.1073/pnas.1432897100] [Cited by in Crossref: 146] [Cited by in F6Publishing: 148] [Article Influence: 7.7] [Reference Citation Analysis]
430 Jensen-Jarolim E, Neumann C, Oberhuber G, Gscheidlinger R, Neuchrist C, Reinisch W, Zuberi RI, Penner E, Liu FT, Boltz-Nitulescu G. Anti-Galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries. J Clin Immunol 2001;21:348-56. [PMID: 11720007 DOI: 10.1023/a:1012240719801] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
431 Ko JKS, Lam FYL, Cheung APL. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol 2005; 11(37): 5787-5794 [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
432 Myles MH, Livingston RS, Livingston BA, Criley JM, Franklin CL. Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis. Infect Immun 2003;71:3885-93. [PMID: 12819073 DOI: 10.1128/IAI.71.7.3885-3893.2003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
433 ten Hove T, van den Blink B, Pronk I, Drillenburg P, Peppelenbosch MP, van Deventer SJ. Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis. Gut. 2002;50:507-512. [PMID: 11889071 DOI: 10.1136/gut.50.4.507] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 3.9] [Reference Citation Analysis]
434 Chen Y, Park J, Joe Y, Park HJ, Jekal SJ, Sato D, Hamada H, Chung HT. Pterostilbene 4'-β-Glucoside Protects against DSS-Induced Colitis via Induction of Tristetraprolin. Oxid Med Cell Longev 2017;2017:9427583. [PMID: 28607633 DOI: 10.1155/2017/9427583] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
435 Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC. Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut. 2002;51:818-826. [PMID: 12427784 DOI: 10.1136/gut.51.6.818] [Cited by in Crossref: 109] [Cited by in F6Publishing: 115] [Article Influence: 5.5] [Reference Citation Analysis]
436 García de Tena J, Manzano L, Leal JC, San Antonio E, Sualdea V, Alvarez-Mon M. Distinctive pattern of cytokine production and adhesion molecule expression in peripheral blood memory CD4+ T cells from patients with active Crohn's disease. J Clin Immunol 2006;26:233-42. [PMID: 16783463 DOI: 10.1007/s10875-006-9016-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
437 Freeman HJ. Application of the Montreal classification for Crohn’s disease to a single clinician database of 1015 patients. Can J Gastroenterol. 2007;21:363-366. [PMID: 17571169 DOI: 10.1155/2007/951526] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
438 Sahin A, Calhan T, Cengiz M, Kahraman R, Aydin K, Ozdil K, Korachi M, Sokmen HM. Serum interleukin 17 levels in patients with Crohn's disease: real life data. Dis Markers 2014;2014:690853. [PMID: 25140070 DOI: 10.1155/2014/690853] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
439 van Nuenen MH, Venema K, van der Woude JC, Kuipers EJ. The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig Dis Sci. 2004;49:485-491. [PMID: 15139503 DOI: 10.1023/b:ddas.0000020508.64440.73] [Cited by in Crossref: 67] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
440 Zijlstra FJ, van Meeteren ME, Garrelds IM, Meijssen MA. Effect of pharmacologically induced smooth muscle activation on permeability in murine colitis. Mediators Inflamm 2003;12:21-7. [PMID: 12745545 DOI: 10.1080/0962935031000096944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
441 Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008;118:560-70. [PMID: 18219394 DOI: 10.1172/JCI32453] [Cited by in Crossref: 79] [Cited by in F6Publishing: 369] [Article Influence: 5.6] [Reference Citation Analysis]
442 Vowinkel T, Kalogeris TJ, Mori M, Krieglstein CF, Granger DN. Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig Dis Sci. 2004;49:556-564. [PMID: 15185857 DOI: 10.1023/B:DDAS.0000026298.72088.f7] [Cited by in Crossref: 87] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
443 Kato K, Fukunaga K, Kamikozuru K, Kashiwamura S, Hida N, Ohda Y, Takeda N, Yoshida K, Iimuro M, Yokoyama Y, Kikuyama R, Miwa H, Matsumoto T. Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's disease. Gut Liver 2011;5:37-45. [PMID: 21461070 DOI: 10.5009/gnl.2011.5.1.37] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
444 Abron JD, Singh NP, Price RL, Nagarkatti M, Nagarkatti PS, Singh UP. Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis. PLoS One. 2018;13:e0199631. [PMID: 30024891 DOI: 10.1371/journal.pone.0199631] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
445 Circu ML, Aw TY. Redox biology of the intestine. Free Radic Res. 2011;45:1245-1266. [PMID: 21831010 DOI: 10.3109/10715762.2011.611509] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 10.3] [Reference Citation Analysis]
446 Guzy C, Schirbel A, Paclik D, Wiedenmann B, Dignass A, Sturm A. Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro. Eur J Nutr 2009;48:12-21. [PMID: 18998044 DOI: 10.1007/s00394-008-0754-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
447 Sica GS, Iaculli E, Benavoli D, Biancone L, Calabrese E, Onali S, Gaspari AL. Laparoscopic versus open ileo-colonic resection in Crohn's disease: short- and long-term results from a prospective longitudinal study. J Gastrointest Surg 2008;12:1094-102. [PMID: 18027061 DOI: 10.1007/s11605-007-0394-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
448 Rivera-Nieves J, Gorfu G, Ley K. Leukocyte adhesion molecules in animal models of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1715-1735. [PMID: 18523998 DOI: 10.1002/ibd.20501] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
449 Cianci R, Frosali S, Pagliari D, Cesaro P, Petruzziello L, Casciano F, Landolfi R, Costamagna G, Pandolfi F. Uncomplicated diverticular disease: innate and adaptive immunity in human gut mucosa before and after rifaximin. J Immunol Res. 2014;2014:696812. [PMID: 25133198 DOI: 10.1155/2014/696812] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
450 Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B, Horwitz BH, Fox JG. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 2003;162:691-702. [PMID: 12547727 DOI: 10.1016/S0002-9440(10)63863-1] [Cited by in Crossref: 223] [Cited by in F6Publishing: 121] [Article Influence: 11.7] [Reference Citation Analysis]
451 Tyagi RK, Jacobse J, Li J, Allaman MM, Otipoby KL, Sampson ER, Wilson KT, Goettel JA. HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice. Front Immunol 2021;12:630204. [PMID: 33717161 DOI: 10.3389/fimmu.2021.630204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
452 Kawashima D, Oshitani N, Jinno Y, Watanabe K, Nakamura S, Higuchi K, Arakawa T. Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease. J Clin Pathol. 2005;58:1057-1063. [PMID: 16189151 DOI: 10.1136/jcp.2004.024828] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
453 García de Tena J, Manzano L, Leal JC, San Antonio E, Sualdea V, Alvarez-Mon M. Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells. J Clin Immunol 2004;24:185-96. [PMID: 15024186 DOI: 10.1023/B:JOCI.0000019784.20191.7f] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
454 Szymańska S, Matuszczyk M, Osuch M, Meglicka M, Szymanska E, Bierła J, Kierkuś J. Inflammatory bowel disease - one entity with many molecular faces. Prz Gastroenterol 2019;14:228-32. [PMID: 31988668 DOI: 10.5114/pg.2019.90249] [Reference Citation Analysis]
455 Iwasa T, Ogino H, Nakamura K, Ihara E, Akiho H, Takayanagi R. Feeding administration of Daikenchuto suppresses colitis induced by naive CD4+ T cell transfer into SCID mice. Dig Dis Sci 2012;57:2571-9. [PMID: 22610884 DOI: 10.1007/s10620-012-2218-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
456 Ustyugova IV, Zhi L, Abramowitz J, Birnbaumer L, Wu MX. IEX-1 deficiency protects against colonic cancer. Mol Cancer Res 2012;10:760-7. [PMID: 22550081 DOI: 10.1158/1541-7786.MCR-11-0556] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
457 Arribas B, Rodríguez-Cabezas ME, Camuesco D, Comalada M, Bailón E, Utrilla P, Nieto A, Concha A, Zarzuelo A, Gálvez J. A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice. Br J Pharmacol. 2009;157:1024-1033. [PMID: 19486007 DOI: 10.1111/j.1476-5381.2009.00270.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
458 Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000;68:7010-7. [PMID: 11083826 DOI: 10.1128/IAI.68.12.7010-7017.2000] [Cited by in Crossref: 908] [Cited by in F6Publishing: 344] [Article Influence: 41.3] [Reference Citation Analysis]
459 Van Spaendonk H, Ceuleers H, Witters L, Patteet E, Joossens J, Augustyns K, Lambeir AM, De Meester I, De Man JG, De Winter BY. Regulation of intestinal permeability: The role of proteases. World J Gastroenterol 2017; 23(12): 2106-2123 [PMID: 28405139 DOI: 10.3748/wjg.v23.i12.2106] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 58] [Article Influence: 14.0] [Reference Citation Analysis]
460 Paclik D, Berndt U, Guzy C, Dankof A, Danese S, Holzloehner P, Rosewicz S, Wiedenmann B, Wittig BM, Dignass AU. Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice. J Mol Med (Berl). 2008;86:1395-1406. [PMID: 18064431 DOI: 10.1007/s00109-007-0290-2] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
461 Schmidt C, Giese T, Goebel R, Schilling M, Marth T, Ruether A, Schreiber S, Zeuzem S, Meuer SC, Stallmach A. Interleukin-18 is increased only in a minority of patients with active Crohn's disease. Int J Colorectal Dis. 2007;22:1013-1020. [PMID: 17318554 DOI: 10.1007/s00384-007-0282-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
462 Barton SG, Rampton DS, Winrow VR, Domizio P, Feakins RM. Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones. 2003;8:329-334. [PMID: 15115285 DOI: 10.1379/1466-1268(2003)008<0329:eohsph>2.0.co;2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
463 Scaldaferri F, Petito V, Lopetuso L, Bruno G, Gerardi V, Ianiro G, Sgambato A, Gasbarrini A, Cammarota G. Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives. Mediators Inflamm 2013;2013:391473. [PMID: 23737647 DOI: 10.1155/2013/391473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
464 Hosomi S, Oshitani N, Kamata N, Sogawa M, Okazaki H, Tanigawa T, Yamagami H, Watanabe K, Tominaga K, Watanabe T, Fujiwara Y, Maeda K, Hirakawa K, Arakawa T. Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis. Clin Exp Immunol 2011;163:215-24. [PMID: 21087446 DOI: 10.1111/j.1365-2249.2010.04290.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
465 Eckert KG, Abbasi-Neureither I, Köppel M, Huber G. Structured physical activity interventions as a complementary therapy for patients with inflammatory bowel disease - a scoping review and practical implications. BMC Gastroenterol 2019;19:115. [PMID: 31266461 DOI: 10.1186/s12876-019-1034-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
466 Shen S, Prame Kumar K, Wen SW, Shim R, Wanrooy BJ, Stanley D, Moore RJ, Van TTH, Robert R, Hickey MJ, Wong CHY. Deficiency of Dietary Fiber Modulates Gut Microbiota Composition, Neutrophil Recruitment and Worsens Experimental Colitis. Front Immunol 2021;12:619366. [PMID: 33708211 DOI: 10.3389/fimmu.2021.619366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
467 Kedia S, Bhatia V, Thareja S, Garg S, Mouli VP, Bopanna S, Tiwari V, Makharia G, Ahuja V. Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial. World J Gastrointest Pharmacol Ther 2017; 8(2): 147-154 [PMID: 28533925 DOI: 10.4292/wjgpt.v8.i2.147] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
468 Boissé L, Van Sickle MD, Sharkey KA, Pittman QJ. Compromised neuroimmune status in rats with experimental colitis. J Physiol 2003;548:929-39. [PMID: 12640019 DOI: 10.1113/jphysiol.2002.034546] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
469 Hart AL, Kamm MA, Knight SC, Stagg AJ. Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn's disease patients and healthy controls. Clin Exp Immunol. 2004;135:137-145. [PMID: 14678275 DOI: 10.1111/j.1365-2249.2004.02347.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
470 Lee JC, Bridger S, McGregor C, Macpherson AJ, Jones JE. Why children with inflammatory bowel disease are diagnosed at a younger age than their affected parent. Gut. 1999;44:808-811. [PMID: 10323881 DOI: 10.1136/gut.44.6.808] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
471 Zhang D, Wei C, Yao J, Cai X, Wang L. Interleukin-10 gene-carrying bifidobacteria ameliorate murine ulcerative colitis by regulating regulatory T cell/T helper 17 cell pathway. Exp Biol Med (Maywood) 2015;240:1622-9. [PMID: 25956685 DOI: 10.1177/1535370215584901] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
472 Kim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver. 2010;4:1-14. [PMID: 20479907 DOI: 10.5009/gnl.2010.4.1.1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
473 Cheng M, Hu S, Wang Z, Pei Y, Fan R, Liu X, Wang L, Zhou J, Zheng S, Zhang T, Lin Y, Zhang M, Tao R, Zhong J. Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation. Oncotarget 2016;7:35643-54. [PMID: 27224922 DOI: 10.18632/oncotarget.9543] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
474 Lin YH, Zhou P, Ma PE, Guo XQ, Xia TY, Shen BF, Li Y, Han GC. Expression of IL-17 in inflammatory bowel disease and synergistic action of IL-17 and LPS on IL-8 expression in intestinal epithelial cells. Shijie Huaren Xiaohua Zazhi 2012; 20(12): 991-997 [DOI: 10.11569/wcjd.v20.i12.991] [Reference Citation Analysis]
475 Maheshwari RA, Balaraman R, Sailor GU, Sen DB. Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats. Indian J Pharmacol. 2015;47:17-21. [PMID: 25821305 DOI: 10.4103/0253-7613.150311] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
476 Deban L, Correale C, Vetrano S, Malesci A, Danese S. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol. 2008;172:1457-1466. [PMID: 18458096 DOI: 10.2353/ajpath.2008070593] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
477 Choi SY, Kang B, Choe YH. Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease. Gut Liver 2019;13:541-8. [PMID: 30970435 DOI: 10.5009/gnl18129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
478 Carvalho AT, Souza H, Carneiro AJ, Castelo-Branco M, Madi K, Schanaider A, Silva F, Pereira Jứnior FA, Pereira MG, Tortori C, Dines I, Carvalho J, Rocha E, Elia C. Therapeutic and prophylactic thalidomide in TNBS-induced colitis: Synergistic effects on TNF-α, IL-12 and VEGF production. World J Gastroenterol 2007; 13(15): 2166-2173 [PMID: 17465495 DOI: 10.3748/wjg.v13.i15.2166] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
479 Sina C, Arlt A, Gavrilova O, Midtling E, Kruse ML, Müerköster SS, Kumar R, Fölsch UR, Schreiber S, Rosenstiel P, Schäfer H. Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB. Inflamm Bowel Dis 2010;16:320-31. [PMID: 19714745 DOI: 10.1002/ibd.21066] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
480 Tokieda S, Komori M, Ishiguro T, Iwakura Y, Takahara K, Inaba K. Dendritic cell immunoreceptor 1 alters neutrophil responses in the development of experimental colitis. BMC Immunol 2015;16:64. [PMID: 26497661 DOI: 10.1186/s12865-015-0129-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
481 Lindsay JO, Sandison A, Cohen P, Brennan FM, Hodgson HJ. IL-10 gene therapy is therapeutic for dextran sodium sulfate-induced murine colitis. Dig Dis Sci 2004;49:1327-34. [PMID: 15387364 DOI: 10.1023/b:ddas.0000037830.22065.71] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
482 Van Assche G, Sandborn WJ, Feagan BG, Salzberg BA, Silvers D, Monroe PS, Pandak WM, Anderson FH, Valentine JF, Wild GE. Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial. Gut. 2006;55:1568-1574. [PMID: 16603634 DOI: 10.1136/gut.2005.089854] [Cited by in Crossref: 103] [Cited by in F6Publishing: 79] [Article Influence: 6.4] [Reference Citation Analysis]
483 Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B, Graziadei I, Dunzendorfer S, Wiedermann CJ, Mürzl E. Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol. 2004;24:74-85. [PMID: 14997037 DOI: 10.1023/b:joci.0000018066.46279.6b] [Cited by in Crossref: 134] [Cited by in F6Publishing: 67] [Article Influence: 7.4] [Reference Citation Analysis]
484 Wen XD, Wang CZ, Yu C, Zhang Z, Calway T, Wang Y, Li P, Yuan CS. Salvia miltiorrhiza (dan shen) significantly ameliorates colon inflammation in dextran sulfate sodium induced colitis. Am J Chin Med 2013;41:1097-108. [PMID: 24117071 DOI: 10.1142/S0192415X13500742] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
485 Howard LM, Miller SD. Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease. Autoimmunity. 2004;37:411-418. [PMID: 15194658 DOI: 10.1080/08916930410001716095] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
486 Vasselon T, Detmers PA. Toll receptors: a central element in innate immune responses. Infect Immun 2002;70:1033-41. [PMID: 11854180 DOI: 10.1128/IAI.70.3.1033-1041.2002] [Cited by in Crossref: 149] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
487 Delmondes LM, Nunes MO, Azevedo AR, Oliveira MM, Coelho LE, Torres-Neto JD. Clinical and Sociodemographic Aspects of Inflammatory Bowel Disease Patients. Gastroenterology Res. 2015;8:207-215. [PMID: 27785298 DOI: 10.14740/gr649w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
488 Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A, Ikonomopoulos J, Gorgoulis VG. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 2005; 11(5): 681-685 [PMID: 15655821 DOI: 10.3748/wjg.v11.i5.681] [Cited by in CrossRef: 128] [Cited by in F6Publishing: 129] [Article Influence: 7.5] [Reference Citation Analysis]
489 Zhang QF, Qiu XF, Zhang CP, Yang JB, Chen ZL. Pathogenic role of macrophage migration inhibitory factor in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2008; 16(15): 1645-1648 [DOI: 10.11569/wcjd.v16.i15.1645] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
490 Tak KH, Ahn E, Kim E. Increase in dietary protein content exacerbates colonic inflammation and tumorigenesis in azoxymethane-induced mouse colon carcinogenesis. Nutr Res Pract 2017;11:281-9. [PMID: 28765774 DOI: 10.4162/nrp.2017.11.4.281] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
491 Poudyal D, Cui X, Mai Le P, Davis T, Hofseth AB, Jin Y, Chumanevich AA, Wargovich MJ, Nagarkatti M, Nagarkatti PS. A limited role of p53 on the ability of a Hexane fraction of American ginseng to suppress mouse colitis. J Biomed Biotechnol. 2012;2012:785739. [PMID: 22899889 DOI: 10.1155/2012/785739] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
492 Spisni E, Valerii MC, De Fazio L, Cavazza E, Borsetti F, Sgromo A, Candela M, Centanni M, Rizello F, Strillacci A. Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli. Mol Ther 2015;23:278-89. [PMID: 25393372 DOI: 10.1038/mt.2014.222] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
493 Dou W, Zhang J, Ren G, Ding L, Sun A, Deng C, Wu X, Wei X, Mani S, Wang Z. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation. Int Immunopharmacol 2014;23:170-8. [PMID: 25194678 DOI: 10.1016/j.intimp.2014.08.025] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 10.1] [Reference Citation Analysis]
494 Danese S, Gasbarrini A. Chemokines in inflammatory bowel disease. J Clin Pathol 2005;58:1025-7. [PMID: 16189145 DOI: 10.1136/jcp.2005.030916] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
495 Belmiro CL, Castelo-Branco MT, Melim LM, Schanaider A, Elia C, Madi K, Pavão MS, de Souza HS. Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats. J Biol Chem 2009;284:11267-78. [PMID: 19258310 DOI: 10.1074/jbc.M807211200] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
496 Ho J, Kurtz CC, Naganuma M, Ernst PB, Cominelli F, Rivera-Nieves J. A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis. J Immunol 2008;180:2573-80. [PMID: 18250468 DOI: 10.4049/jimmunol.180.4.2573] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
497 Shi BB, Huang CF, Zhu Q. Clinical analysis and colonoscopic manifestations in 120 patients with ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2008; 16(17): 1951-1953 [DOI: 10.11569/wcjd.v16.i17.1951] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
498 Polese L, Angriman I, Franchis GD, Cecchetto A, Sturniolo GC, D’Incà R, Scarpa M, Ruffolo C, Norberto L, Frego M, D’Amico DF. Persistence of high CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis. World J Gastroenterol 2005; 11(34): 5303-5308 [PMID: 16149136 DOI: 10.3748/wjg.v11.i34.5303] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
499 Paclik D, Danese S, Berndt U, Wiedenmann B, Dignass A, Sturm A. Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS One. 2008;3:e2629. [PMID: 18612433 DOI: 10.1371/journal.pone.0002629] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 5.1] [Reference Citation Analysis]
500 Herfarth H, Göke M, Hellerbrand C, Mühlbauer M, Vogl D, Schölmerich J, Rogler G. Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease. Int J Colorectal Dis. 2003;18:401-405. [PMID: 12904997 DOI: 10.1007/s00384-003-0477-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
501 Azer SA, Azer S. Bibliometric analysis of the top-cited gastroenterology and hepatology articles. BMJ Open 2016;6:e009889. [PMID: 26857105 DOI: 10.1136/bmjopen-2015-009889] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
502 Stremmel W, Merle U, Zahn A, Autschbach F, Hinz U, Ehehalt R. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut. 2005;54:966-971. [PMID: 15951544 DOI: 10.1136/gut.2004.052316] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 5.9] [Reference Citation Analysis]
503 Lügering A, Floer M, Lügering N, Cichon C, Schmidt MA, Domschke W, Kucharzik T. Characterization of M cell formation and associated mononuclear cells during indomethacin-induced intestinal inflammation. Clin Exp Immunol 2004;136:232-8. [PMID: 15086385 DOI: 10.1111/j.1365-2249.2004.02438.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
504 Annovazzi A, Biancone L, Caviglia R, Chianelli M, Capriotti G, Mather SJ, Caprilli R, Pallone F, Scopinaro F, Signore A. 99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn’s disease. Eur J Nucl Med Mol Imaging. 2003;30:374-382. [PMID: 12634965 DOI: 10.1007/s00259-002-1069-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
505 Rufo PA, Bousvaros A. Current therapy of inflammatory bowel disease in children. Paediatr Drugs 2006;8:279-302. [PMID: 17037946 DOI: 10.2165/00148581-200608050-00002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 4.7] [Reference Citation Analysis]
506 Santucci L, Agostini M, Bruscoli S, Mencarelli A, Ronchetti S, Ayroldi E, Morelli A, Baldoni M, Riccardi C. GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut. 2007;56:52-60. [PMID: 16763055 DOI: 10.1136/gut.2006.091181] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
507 Kang K, Bae JH, Han K, Kim ES, Kim TO, Yi JM. A Genome-Wide Methylation Approach Identifies a New Hypermethylated Gene Panel in Ulcerative Colitis. Int J Mol Sci. 2016;17:pii E1291. [PMID: 27517910 DOI: 10.3390/ijms17081291] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
508 Fruet AC, Seito LN, Rall VL, Di Stasi LC. Dietary intervention with narrow-leaved cattail rhizome flour (Typha angustifolia L.) prevents intestinal inflammation in the trinitrobenzenesulphonic acid model of rat colitis. BMC Complement Altern Med 2012;12:62. [PMID: 22559191 DOI: 10.1186/1472-6882-12-62] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
509 Yan Y, Vasudevan S, Nguyen HT, Merlin D. Intestinal epithelial CD98: an oligomeric and multifunctional protein. Biochim Biophys Acta 2008;1780:1087-92. [PMID: 18625289 DOI: 10.1016/j.bbagen.2008.06.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
510 Di Gioia S, Hossain MN, Conese M. Biological properties and therapeutic effects of plant-derived nanovesicles. Open Med (Wars) 2020;15:1096-122. [PMID: 33336066 DOI: 10.1515/med-2020-0160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
511 Chhaya V, Pollok R. The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference? F1000Prime Rep 2013;5:50. [PMID: 24273651 DOI: 10.12703/P5-50] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
512 Zimmerman MA, Rahman NT, Yang D, Lahat G, Lazar AJ, Pollock RE, Lev D, Liu K. Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance. Cancer Res 2012;72:4724-32. [PMID: 22805310 DOI: 10.1158/0008-5472.CAN-12-1347] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
513 Cho MK, Park MK, Kang SA, Choi SH, Ahn SC, Yu HS. Trichinella spiralis infection suppressed gut inflammation with CD4(+)CD25(+)Foxp3(+) T cell recruitment. Korean J Parasitol 2012;50:385-90. [PMID: 23230342 DOI: 10.3347/kjp.2012.50.4.385] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
514 Liao CM, Zimmer MI, Wang CR. The functions of type I and type II natural killer T cells in inflammatory bowel diseases. Inflamm Bowel Dis 2013;19:1330-8. [PMID: 23518808 DOI: 10.1097/MIB.0b013e318280b1e3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
515 Aceituno M, Panés J. Patogenia e inmunoterapia de la enfermedad inflamatoria intestinal: lecciones de los modelos animales. Gastroenterología y Hepatología 2005;28:576-90. [DOI: 10.1157/13080611] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
516 Mielants H, De Keyser F, Baeten D, Van den Bosch F. Gut inflammation in the spondyloarthropathies. Curr Rheumatol Rep 2005;7:188-94. [PMID: 15918994 DOI: 10.1007/s11926-996-0038-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
517 Lv QK, Liu JX, Li SN, Gao YJ, Lv Y, Xu ZP, Huang BX, Xu SY, Yang DX, Zeng YL, Liu DF, Wang W. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model. Int J Mol Sci 2015;16:26654-66. [PMID: 26561804 DOI: 10.3390/ijms161125985] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
518 Sfar I, Aleya WB, Mouelhi L, Aouadi H, Rhomdhane TB, Makhlouf M, Ayed-Jendoubi S, Gargaoui H, Najjar T, Abdallah TB, Ayed K, Gorgi Y. Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia. World J Gastroenterol 2010; 16(4): 479-483 [PMID: 20101775 DOI: 10.3748/wjg.v16.i4.479] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
519 Lackeyram D, Young D, Kim CJ, Yang C, Archbold TL, Mine Y, Fan MZ. Interleukin-10 is differentially expressed in the small intestine and the colon experiencing chronic inflammation and ulcerative colitis induced by dextran sodium sulfate in young pigs. Physiol Res 2017;66:147-62. [PMID: 27782738 DOI: 10.33549/physiolres.933259] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
520 Stio M, Treves C, Martinesi M, d’Albasio G, Bagnoli S, Bonanomi AG. Effect of anti-TNF therapy and vitamin D derivatives on the proliferation of peripheral blood mononuclear cells in Crohn’s disease. Dig Dis Sci. 2004;49:328-335. [PMID: 15104379 DOI: 10.1023/b:ddas.0000017460.90887.11] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
521 Prager M, Büttner J, Haas V, Baumgart DC, Sturm A, Zeitz M, Büning C. The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action. Int J Colorectal Dis 2012;27:565-73. [PMID: 22065112 DOI: 10.1007/s00384-011-1345-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
522 Koch TR, Yuan LX, Fink JG, Petro A, Opara EC. Induction of enlarged intestinal lymphoid aggregates during acute glutathione depletion in a murine model. Dig Dis Sci 2000;45:2115-21. [PMID: 11215724 DOI: 10.1023/a:1026423420759] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
523 Pelia R, Venkateswaran S, Matthews JD, Haberman Y, Cutler DJ, Hyams JS, Denson LA, Kugathasan S. Profiling non-coding RNA levels with clinical classifiers in pediatric Crohn's disease. BMC Med Genomics 2021;14:194. [PMID: 34325702 DOI: 10.1186/s12920-021-01041-7] [Reference Citation Analysis]
524 Gonzalez-Rey E, Varela N, Sheibanie AF, Chorny A, Ganea D, Delgado M. Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. Proc Natl Acad Sci U S A 2006;103:4228-33. [PMID: 16537513 DOI: 10.1073/pnas.0508997103] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 4.9] [Reference Citation Analysis]
525 Kanai T, Totsuka T, Tezuka K, Watanabe M. ICOS costimulation in inflammatory bowel disease. J Gastroenterol 2002;37 Suppl 14:78-81. [PMID: 12572871 DOI: 10.1007/BF03326419] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
526 Singh UP, Singh NP, Singh B, Mishra MK, Nagarkatti M, Nagarkatti PS, Singh SR. Stem cells as potential therapeutic targets for inflammatory bowel disease. Front Biosci (Schol Ed). 2010;2:993-1008. [PMID: 20515838 DOI: 10.2741/s115] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
527 Paul G, Bataille F, Obermeier F, Bock J, Klebl F, Strauch U, Lochbaum D, Rümmele P, Farkas S, Schölmerich J. Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin Exp Immunol. 2005;140:547-555. [PMID: 15932518 DOI: 10.1111/j.1365-2249.2005.02775.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 5.1] [Reference Citation Analysis]
528 Zhang Z, Rosenbaum JT, Zhong W, Lim C, Hinrichs DJ. Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut? Semin Immunopathol 2010;32:55-70. [PMID: 20119686 DOI: 10.1007/s00281-009-0190-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
529 González R, de Medina FS, Martínez-Augustin O, Nieto A, Gálvez J, Risco S, Zarzuelo A. Anti-inflammatory effect of diosmectite in hapten-induced colitis in the rat. Br J Pharmacol 2004;141:951-60. [PMID: 14993105 DOI: 10.1038/sj.bjp.0705710] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 3.4] [Reference Citation Analysis]
530 Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Alterations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic. World J Gastroenterol 2007;13:6031-6. [PMID: 18023095 DOI: 10.3748/wjg.v13.45.6031] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
531 Xiao WB, Liu YL. Changes of CD8+CD28- T regulatory cells in rat model of colitis induced by 2,4-dinitrofluorobenzene. World J Gastroenterol 2003; 9(11): 2528-2532 [PMID: 14606090 DOI: 10.3748/wjg.v9.i11.2528] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
532 Dacquay LC, Tsang D, Chan D, Parkinson J, Philpott DJ, McMillen DR. E.coli Nissle increases transcription of flagella assembly and formate hydrogenlyase genes in response to colitis. Gut Microbes 2021;13:1994832. [PMID: 34751631 DOI: 10.1080/19490976.2021.1994832] [Reference Citation Analysis]
533 Moussata D, Goetz M, Gloeckner A, Kerner M, Campbell B, Hoffman A, Biesterfeld S, Flourie B, Saurin JC, Galle PR. Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. Gut. 2011;60:26-33. [PMID: 20980342 DOI: 10.1136/gut.2010.213264] [Cited by in Crossref: 81] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
534 Colombel JF, Rutgeerts P, Malchow H, Jacyna M, Nielsen OH, Rask-Madsen J, Van Deventer S, Ferguson A, Desreumaux P, Forbes A. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn’s disease. Gut. 2001;49:42-46. [PMID: 11413109 DOI: 10.1136/gut.49.1.42] [Cited by in Crossref: 150] [Cited by in F6Publishing: 145] [Article Influence: 7.1] [Reference Citation Analysis]
535 Rana SV, Sharma S, Malik A, Kaur J, Prasad KK, Sinha SK, Singh K. Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease. Dig Dis Sci. 2013;58:2594-2598. [PMID: 23649377 DOI: 10.1007/s10620-013-2694-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 6.9] [Reference Citation Analysis]
536 Hayashi Y, Narumi K, Tsuji S, Tsubokawa T, Nakaya MA, Wakayama T, Zuka M, Ohshima T, Yamagishi M, Okada T. Impact of adrenomedullin on dextran sulfate sodium-induced inflammatory colitis in mice: insights from in vitro and in vivo experimental studies. Int J Colorectal Dis. 2011;26:1453-1462. [PMID: 21674139 DOI: 10.1007/s00384-011-1254-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
537 Bourgonje AR, von Martels JZH, Bulthuis MLC, van Londen M, Faber KN, Dijkstra G, van Goor H. Crohn's Disease in Clinical Remission Is Marked by Systemic Oxidative Stress. Front Physiol 2019;10:499. [PMID: 31080419 DOI: 10.3389/fphys.2019.00499] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
538 Schmidt C, Giese T, Ludwig B, Menges M, Schilling M, Meuer SC, Zeuzem S, Stallmach A. Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity. Int J Colorectal Dis 2006;21:419-26. [PMID: 16133004 DOI: 10.1007/s00384-005-0024-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
539 Lee JH, Cheon JH, Kim ES, Chung MJ, Kang W, Kim DH, Ha YJ, Park JJ, Kim TI, Kim WH. The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis. Dig Dis Sci 2010;55:1406-12. [PMID: 19507028 DOI: 10.1007/s10620-009-0847-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
540 Lubbad A, Oriowo MA, Khan I. Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis. Mol Cell Biochem. 2009;322:127-135. [PMID: 19002562 DOI: 10.1007/s11010-008-9949-4] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 6.9] [Reference Citation Analysis]
541 Tezcan G, Martynova EV, Gilazieva ZE, McIntyre A, Rizvanov AA, Khaiboullina SF. MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies. Front Pharmacol 2019;10:451. [PMID: 31118894 DOI: 10.3389/fphar.2019.00451] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
542 Koon HW, Shih D, Karagiannides I, Zhao D, Fazelbhoy Z, Hing T, Xu H, Lu B, Gerard N, Pothoulakis C. Substance P modulates colitis-associated fibrosis. Am J Pathol 2010;177:2300-9. [PMID: 20889569 DOI: 10.2353/ajpath.2010.100314] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
543 Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, Tsuboi K, Sugimoto Y, Kobayashi T, Miyachi Y, Ichikawa A, Narumiya S. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 2002;109:883-93. [PMID: 11927615 DOI: 10.1172/JCI14459] [Cited by in Crossref: 8] [Cited by in F6Publishing: 152] [Article Influence: 0.4] [Reference Citation Analysis]
544 Puga Yung GL, Fidler M, Albani E, Spermon N, Teklenburg G, Newbury R, Schechter N, van den Broek T, Prakken B, Billetta R, Dohil R, Albani S. Heat shock protein-derived T-cell epitopes contribute to autoimmune inflammation in pediatric Crohn's disease. PLoS One 2009;4:e7714. [PMID: 19888320 DOI: 10.1371/journal.pone.0007714] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
545 Borruel N, Carol M, Casellas F, Antolin M, de Lara F, Espin E, Naval J, Guarner F, Malagelada JR. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut. 2002;51:659-664. [PMID: 12377803 DOI: 10.1136/gut.51.5.659] [Cited by in Crossref: 216] [Cited by in F6Publishing: 201] [Article Influence: 10.8] [Reference Citation Analysis]
546 Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J Clin Invest. 2001;108:601-609. [PMID: 11518734 DOI: 10.1172/jci12821] [Cited by in Crossref: 381] [Cited by in F6Publishing: 187] [Article Influence: 18.1] [Reference Citation Analysis]